- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Regulations 4(2) and 5(1)
The alphabetical list set out in column 2 of this Schedule contains one or more of the names of each of the substances referred to in regulation 4(2); in certain cases a name is given of a group of substances, the names of particular examples of which are also given, and in such a case all substances comprised in the group are included, whether or not more specifically named.
The numbers given in columns 1, 3 and 4 are for information only. Those in column 3 are cross-references to other names listed for the same substances (except that where a name is that of a group of substances, the cross-references are to particular examples of that group, and any cross-reference in parenthesis is to the name of a group of substances within which the particular substance falls). Those in column 4 are cross-references to Annex II of the Directive, from which this Schedule is derived.
(1) | (2) | (3) | (4) |
---|---|---|---|
Number in this Schedule | Name of substance | Cross-reference to this Schedule | Cross-reference to Annex II of the Directive |
1 | Acenocoumarol (INN) | 396 | 254 |
2 | Acetonitrile | — | 393 |
3 | 3-(α-Acetonylbenzyl)-4-hydroxycoumarin and its salts | 398, 760 | 203 |
4 | 2-Acetoxyethyltrimethylammonium hydroxide and its salts | 6 | 2 |
5 | 2-Acetylamino-5-chlorobenzoxazole | 164 | 1 |
6 | Acetylcholine and its salts | 4 | 2 |
7 | Acetylene chlorides | 249, 757 | 126 |
8 | Acetylenic alcohols, their esters, ethers and salts | 17 | 16 |
9 | Acetylethyltetramethyltetralin (AETT) | 341 | 362 |
10 | 7α-Acetylthio-3-oxopregn-4-ene-17α,17β-propionolactone | 649 | 4 |
11 | Aconitine and its salts | — | 12 |
12 | Aconitum napellus L. (leaves, roots and galenical preparations) | — | 11 |
13 | Adonis vernalis L. and its preparations | — | 13 |
14 | Adrenaline | 269, 314 | 14 |
15 | Alkali pentacyanonitrosylferrate(2-) | 602–3, 644–5 | 255 |
16 | O-Alkyldithiocarbonic acids, salts of | 761 | 336 |
17 | Alkyne alcohols, their esters, ethers and salts | 8 | 16 |
18 | Alloclamide (INN) and its salts | 22 | 19 |
19 | Allyl isothiocyanate | — | 18 |
20 | 2-(4-Allyl-2-methoxyphenoxy)-N,N-diethylacetamide and its salts | — | 224 |
21 | N-Allylnormorphine, its salts and ethers | 492 | 20 |
22 | 2-Allyloxy-4-chloro-N-[2-(diethylamino)-ethyl]benzamide and its salts | 18 | 19 |
23 | Alypine and its salts | 45, 109 | 143 |
24 | Ambenonium chloride (INN) | (527) | 132 |
25 | 4-(or p-)Aminobenzoic acid esters | — | 167 |
26 | 2-Amino-1,2-bis(4-methoxyphenyl)ethanol and its salts | — | 29 |
27 | Aminocaproic acid (INN) and its salts | 31 | 7 |
28 | 2-Amino-5-chlorobenzoxazole | 768 | 24 |
29 | 4-Amino-N-(2-diethylaminoethyl)benzamide, its salts and derivatives | 607 | 25 |
30 | Aminoheptane, its isomers and salts | 748 | 25 |
31 | 6-Aminohexanoic acid and its salts | 27 | 7 |
32 | α-(Aminomethyl)-3,4-dihydroxybenzyl alcohol and its salts | 517–8 | 257 |
33 | 4-Amino-N10-methylfolic acid | 452 | 6 |
34 | 2-Amino-6-methylheptane and its salts | 287, 523 | 28 |
35 | 2-Amino-4-methylhexane and its salts | 288, 471 | 30 |
36 | 2-Amino-4-nitrophenol | — | 383 |
37 | 2-Amino-5-nitrophenol | — | 384 |
38 | 4-Amino-2-nitrophenol | — | 412 |
39 | 4-(or p-)Aminosalicylic acid and its salts | — | 31 |
40 | Aminotoluenes, their isomers, salts and halogenated and sulphonated derivatives | 716 | 32 |
41 | Aminoxylenes, their isomers, salts and halogenated and sulphonated derivatives | 763 | 33 |
42 | Amitriptyline (INN) and its salts | 283 | 146 |
43 | Ammi majus and its galencial preparations | — | 35 |
44 | Amphetamine (INN), its salts and derivatives and salts of those derivatives | (678) | 21 |
45 | Amydricaine and its salts | 23, 109 | 143 |
46 | Amylene chloride | 250 | 36 |
47 | Amyl 4-dimethylaminobenzoate, mixed isomers | 532 | 381 |
48 | Amyl nitrites | — | 247 |
49 | Amylobarbitone and its salts | (69) | 220 |
50 | Amylocaine and its salts | 281 | 50 |
51 | Anamirta cocculus L. (fruit) | — | 106 |
52 | Substances with androgenic effect | — | 37 |
53 | Aniline, its salts and halogenated and sulphonated derivatives | — | 22 |
54 | Anthracene oil | — | 38 |
55 | Anti-androgens with steroid structure | — | 390 |
56 | Antibiotics | — | 39 |
57 | Antimony and its compounds | — | 40 |
58 | Apocynum cannabinum L. and its preparations | — | 41 |
59 | Apomorphine and its salts | 694 | 42 |
60 | Apronalide | 419 | 216 |
61 | Arecoline | 482 | 238 |
62 | Aristolochic acid and its salts | — | 365 |
63 | Arsenic and its preparations | — | 43 |
64 | Atropa belladonna L. and its preparations | — | 44 |
65 | Atropine, its salts and derivatives | — | 45 |
66 | Azacyclonol (INN) and its salts | 304 | 286 |
67 | Azamethonium bromide (INN) | (473) | 121 |
68 | Barbitone and its salts | (69) | 220 |
69 | Barbiturates | various | 220 |
70 | Barium salts (except barium sulphate, barium sulphide under the condition laid down in Part I of Schedule 2 for alkaline earth sulphides, and lakes, salts and pigments prepared from those colouring agents identified in column 1 of Schedule 3 by “*” immediately after the name or colour index number) | — | 46 |
71 | Bemegride (INN) and its salts | 336, 337 | 183 |
72 | Benactyzine (INN) | 257 | 157 |
73 | Bendrofluazide and its derivatives | 74, 90 | 53 |
74 | Bendroflumethiazide (INN) and its derivatives | 73, 90 | 53 |
75 | Benzamine and its salts | 741 | 51 |
76 | Benzatropine (INN) and its salts | 300 | 158 |
77 | Benzazepines, their salts and derivatives | 89 | 49 |
78 | Benzene | — | 47 |
79 | Benzene-1,2-diol | 153, 627 | 408 |
80 | Benzene-1,2,3-triol | 628 | 409 |
81 | Benzethonium chloride (INN) | 92 | 415 |
82 | 2-Benzhydryloxyethyldimethylamine and its salts | 295 | 339 |
83 | Benzidine | 242 | 26 |
84 | Benzilonium bromide (INN) | 95 | 60 |
85 | 2-Benziloyloxymethyl-1,1-dimethylpyrrolidinium methyl sulphate | 599 | 239 |
86 | Benzimidazolone | 87, 266 | 48 |
87 | Benzimidazol-2(3H)-one | 86, 266 | 48 |
88 | Benzoates of 4-hydroxy-3-methoxycinnamyl alcohol (except natural content of essences) | 211 | 357 |
89 | Benzodiazepines, their salts and derivatives | 77 | 49 |
90 | Benzothiadiazine and its derivatives | 73, 74 | 53 |
91 | Benzoyl peroxide | — | 382 |
92 | Benzyl(dimethyl)(2-{2-[4-(1,1,3,3-tetramethybutyl)phenoxy]ethoxy}-ethyl)ammonium chloride | 81 | 415 |
93 | 3-(N-Benzylhydrazinocarbonyl)-5-methylisoxazole | 414 | 52 |
94 | Benzylideneacetone | 564 | 356 |
95 | 3-Benzyloxy-1,1-diethylpyrrolidine hydrobromide | 84 | 60 |
96 | 4-Benzyloxyphenol | (390), 487 | 178 |
97 | 2-[Benzyl-N-(2-pyridyl)amino]-ethyldimethylamine | 623, 745 | 347 |
98 | Bergapten(e) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
99 | Beryllium and its compounds | — | 54 |
100 | Betamethasone (INN) | (360) | 300 |
101 | Betoxycaine (INN) and its salts | 256 | 23 |
102 | BHC (ISO) (gamma-BHC) | 369, 371, 428 | 195 |
103 | Bietamiverine (INN) | 260 | 287 |
104 | 1,6-Bis(2-chloroethylamino)-1,6-dideoxymannitol and its salts | 436 | 89 |
105 | 2-[Bis(2-chloroethyl)amino]-1-oxa-3-aza-2-phosphacyclohexane 2-oxide and its salts | 108, 230 | 88 |
106 | N,N-Bis(2-chloroethyl)methylamine and its salts | 160, 490 | 87 |
107 | N,N-Bis(2-chloroethyl)methylamine N-oxide and its salts | 491 | 86 |
108 | N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-ylamine p-oxide and its salts | 105, 230 | 88 |
109 | 1,1-Bis(dimethylaminomethyl)propyl benzoate and its salts | 23, 45 | 143 |
110 | Bis(hydroxyalkyl)amines, not further N-substituted | 254, 273, 640 | 411 |
111 | 2,2-Bis(hydroxymethyl)butan-1-ol trinitrate | 613 | 206 |
112 | 2,6-Bis(β-hydroxyphenethyl)-1-methylpiperidine and its salts | 430 | 219 |
113 | 3,3-Bis(4-hydroxyphenyl)phthalide | 557 | 417 |
114 | Bis(8-hydroxyquinolinium) sulphate, except for the uses provided for in entry number 51 in Part 1 of Schedule 2 | (400, 531) | 395 |
115 | Bithionol (INN) | 705 | 352 |
116 | Bretylium tosilate (INN) (Bretylium tosylate) | 119 | 56 |
117 | Bromine, elemental | — | 55 |
118 | Bromisoval (INN) | 121 | 58 |
119 | p-Bromobenzylethyldimethylammonium p-toluenesulphonate | 116 | 56 |
120 | 2-Bromo-2-ethylbutyrylurea | 149 | 57 |
121 | 2-Bromo-3-methylbutylrylurea | 118 | 58 |
122 | 1-p-Bromophenyl-1-(2-pyridyl)-3-dimethylaminopropane and its salts | 123 | 59 |
123 | Brompheniramine (INN) and its salts | 122 | 59 |
124 | Brucine | — | 62 |
125 | Butanilicaine (INN) and its salts | 466 | 90 |
126 | Butobarbitone and its salts | (69) | 220 |
127 | Butopiprine (INN) and its salts | 129 | 288 |
128 | 2-Butoxy-N-(2-diethylaminoethyl)-cinchoninamide and its salts | 191 | 129 |
129 | 2-Butoxyethyl phenyl(piperidino)acetate and its salts | 127 | 288 |
130 | 1-Butyl-3-(N-crotonoylsulphanilyl)urea | — | 108 |
131 | 4-Butyl-1,2-diphenylpyrazolidine-3,5-dione | 563 | 67 |
132 | 4-tert-Butyl-3-methoxy-2,6-dinitrotoluene | 489 | 414 |
133 | 4-Butyl-1-phenylpyrazolidine-3,5-dione | 486 | 64 |
134 | 1-Butyl-3-(p-methylbenzenesulphonyl)urea | 715 | 65 |
135 | 1-Butyl-3-sulphanilylurea | 150 | 66 |
136 | 4-Butylthiobenzhydryl 2-(dimethylamino)ethyl sulphide | 143 | 140 |
137 | Cadmium and its compounds | — | 68 |
138 | Calabar bean | 585 | 281 |
139 | Calciferol | 316, (759) | 335 |
140 | Cantharides, Cantharis vesicatoria | 647 | 69 |
141 | Cantharidin | 378 | 70 |
142 | Captan (ISO) | 734 | 370 |
143 | Captodiame (INN) | 136 | 140 |
144 | Caramiphen (INN) and its salts | 567 | 169 |
145 | N-(3-Carbamoyl-3,3-diphenylpropyl)-N,N-diisopropylmethylammonium salts | 418 | 156 |
146 | Carbazole, nitroderivatives of | 508 | 72 |
147 | Carbon disulphide | — | 73 |
148 | Carbon tetrachloride | 690 | 315 |
149 | Carbromal (INN) | 120 | 57 |
150 | Carbutamide (INN) | 135 | 66 |
151 | Carisoprodol (INN) | 480 | 235 |
152 | Catalase | — | 74 |
153 | Catechol | 79, 627 | 408 |
154 | Cells, tissues or products of human origin | — | 416 |
155 | Cephaeline and its salts | — | 75 |
156 | Chenopodium ambrosioides (essential oil) | — | 76 |
157 | Cherry laurel water | 618 | 291 |
158 | Chloral hydrate | 732 | 77 |
159 | Chlorine | — | 78 |
160 | Chlormethine (INN) and its salts | 106, 490 | 87 |
161 | Chlormezanone (INN) | 175 | 91 |
162 | 4-Chlorobenzene-1,3-disulfonamide | 194 | 85 |
163 | 5-Chloro-1,3-benzoxazol-2(3H)-one | 186 | 82 |
164 | N-5-Chlorobenzoxazol-2-ylacetamide | 5 | 1 |
165 | 2-Chloro-4-dimethylamino-6-methylpyrimidine | 169, 216 | 83 |
166 | 2-Chloro-9-[3-(dimethylamino)-propylidene]thioxanthene (cis-form) and its salts | 183 | 84 |
167 | Chloroethane | 327 | 96 |
168 | Chloroform | 733 | 366 |
169 | 2-Chloro-6-methylpyrimidin-4-yldimethylamine | 165, 216 | 83 |
170 | Chlorophacinone (ISO) | 176 | 93 |
171 | 1-(p-Chloro-α-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine | 401 | 240 |
172 | 2-(4-Chlorophenyl)-1-[4-(2-diethylaminoethoxyl)phenyl]-1-p-tolylethanol | 744 | 92 |
173 | 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one | 368 | 185 |
174 | 2-(4-Chlorophenyl)-3-methylbutane-2,3-diol | 551 | 95 |
175 | 2-(4-Chlorophenyl-3-methyl-1,3-thiazinan-4-one 1,1-dioxide | 161 | 91 |
176 | 2-[2-(4-Chlorophenyl)-2-phenylacetyl]indane-1,3-dione | 170 | 93 |
177 | 2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl-(dimethyl)amine | 180 | 94 |
178 | Chloropicrin | 735 | 325 |
179 | 3-(4-Chloro-3-sulphamoylphenyl)-3-hydroxyisoindolin-1-one | 184, 185 | 262 |
180 | Chlorphenoxamine (INN) | 177 | 94 |
181 | Chlorpromazine (INN) | (558) | 320 |
182 | Chlorpropamide (INN) | 614 | 79 |
183 | Chlorprothixene (INN) and its salts | 166 | 84 |
184 | Chlortalidone (INN) | 179, 185 | 262 |
185 | Chlorthalidone | 179, 184 | 262 |
186 | Chlorzoxazone (INN) | 163 | 82 |
187 | Cholecalciferol | (759) | 335 |
188 | Choline salts and their esters | — | 168 |
189 | Chromium, chromic acid and salts of the acid | — | 97 |
190 | Chrysoidine citrate hydrochloride | 562 | 81 |
191 | Cinchocaine (INN) and its salts | 128 | 129 |
192 | Cincophen (INN), its salts and derivatives and salts of those derivatives | 577 | 8 |
193 | Claviceps purpurea Tul., its alkaloids and galenical preparations | 317 | 98 |
194 | Clofenamide (INN) | 162 | 85 |
195 | Clofenotane (INN) | 232, 731 | 123 |
196 | Cobalt benzenesulphonate | — | 101 |
197 | Cocculin | 589 | 282 |
198 | Colchicine, its salts and derivatives | — | 102 |
199 | Colchicoside and its derivatives | — | 103 |
200 | Colchicum autumnale L. and its galenical preparations | — | 104 |
201 | Colouring agent CI 12075 and its lakes, pigments and salts | — | 397 |
202 | Colouring agent CI 12140 | — | 378 |
203 | Colouring agent CI 13065 | — | 387 |
204 | Colouring agent CI 15585 | — | 401 |
205 | Colouring agent CI 26105 | — | 379 |
206 | Colouring agent CI 42535 | — | 388 |
207 | Colouring agents CI 42555, 42555:1 and 42555:2 | — | 380 |
208 | Colouring agent CI 42640 | — | 386 |
209 | Colouring agent CI 61554 | — | 389 |
210 | Colouring agent CI 45170 and CI 45170:1 | — | 398 |
211 | Coniferyl benzoate (except natural content of essences) | 88 | 357 |
212 | Coniine | 615 | 290 |
213 | Conium maculatum L. (fruit, powder, galenical preparations) | — | 99 |
214 | Convallatoxin | — | 105 |
215 | Coumetarol (INN) | 454 | 225 |
216 | Crimidine (ISO) | 165, 169 | 83 |
217 | Croton tiglium (oil) | — | 107 |
218 | Curare and curarine | — | 109 |
219 | Curarizants, synthetic | — | 110 |
220 | 1-(3-Cyano-3,3-diphenylpropyl)-4-ethoxycarbonyl-4-phenylpiperidinium chloride | 296 | 80 |
221 | Cyclarbamate (INN) | 229 | 122 |
222 | Cyclizine (INN) and its salts | 301 | 159 |
223 | Cyclobarbitone and its salts | (69) | 220 |
224 | Cyclocoumarol | 267 | 234 |
225 | 2-α-Cyclohexylbenzyl(N,N',N'-tetraethyl)trimethylenediamine | 552 | 112 |
226 | 2-Cyclohexyl-3,5-dimethylphenol and its salts | 228 | 113 |
227 | 1-Cyclohexyl-3-(p-methylbenzenesulphonyl)urea | 363 | 100 |
228 | Cyclomenol (INN) and its salts | 226 | 113 |
229 | Cyclopentane-1,1-dimethanol dicarbanilate | 221 | 122 |
230 | Cyclophosphamide (INN) and its salts | 105, 108 | 88 |
231 | Datura stramonium L. and its galenical preparations | 651 | 301 |
232 | DDT (ISO) (pp'-DDT) | 195, 731 | 123 |
233 | Deanol aceglumate (INN) | 278 | 3 |
234 | Decamethonium bromide (INN) | (235) | 214 |
235 | Decamethylenebis(trimethylammonium) salts | 234 | 214 |
236 | Dextromethorphan (INN) and its salts | 457 | 226 |
237 | Dextropropoxyphene (INN) | 280 | 116 |
238 | O,O'-Diacetyl-N-allyl-N-normorphine | — | 117 |
239 | 2,4-Diaminoanisole and its salts | 455, 461 | 376 |
240 | 2,5-Diaminoanisole and its salts | 456, 460 | 377 |
241 | 1,2-Diaminobenzene and its salts | 570 | 363 |
242 | p,p'-Diaminodiphenyl | 82 | 26 |
243 | 2-(2,4-Diaminophenyl)ethanol and its salts | — | 407 |
244 | 1,4:3,6-Dianhydrosorbitol 2,5-dinitrate | 421 | 148 |
245 | 5-(α,β-Dibromophenethyl)-5-methylhydantoin | — | 119 |
246 | Dibromosalicylanilides | 247, 443 | 351 |
247 | Dibromsalan (INN) | (246) | 351 |
248 | Dichloroethanes | 329, 334 | 125 |
249 | Dichloroethylenes | 7, 757 | 126 |
250 | 2,3-Dichloro-2-methylbutane | 46 | 36 |
251 | Dichlorosalicylanilides | — | 349 |
252 | Dicoumarin | 253, 469 | 231 |
253 | Dicoumarol (INN) | 252, 469 | 231 |
254 | Diethanolamine | (110, 640) | 411 |
255 | 2-(Diethylaminoethoxy)ethyl α-phenylpiperidine-1-acetate dimethiodide | 598 | 137 |
256 | 2-Diethylaminoethyl 3-amino-4-butoxybenzoate and its salts | 101 | 23 |
257 | 2-Diethylaminoethyl benzilate | 72 | 157 |
258 | 2-Diethylaminoethyl 4-ethoxybenzoate and its salts | 410, 536 | 179 |
259 | 2-Diethylaminoethyl 3-hydroxy-4-phenylbenzoate and its salts | — | 128 |
260 | 2-Diethylaminoethyl phenyl(piperidino)acetate | 103 | 287 |
261 | 3-Diethylaminopropyl cinnamate | — | 130 |
262 | Diethyl 4-nitrophenyl phosphate | 534 | 170 |
263 | O,O-Diethyl O-4-nitrophenyl phosphorothioate | 535 | 131 |
264 | Difencloxazine (INN) | 566 | 270 |
265 | Digitaline and all heterosides of Digitalis purpurea L. | — | 134 |
266 | 4,5-Dihydrobenzimidazol-4-one | 86, 87 | 48 |
267 | 3,4-Dihydro-2-methoxy-2-methyl-4-phenyl-2H,5H-pyrano[3,2-c]-[1]-benzopyran-5-one | 224 | 234 |
268 | Dihydrotachysterol (INN) | — | 342 |
269 | 3,4-Dihydroxy-α-(methylaminomethyl)benzyl alcohol | 14, 314 | 14 |
270 | 4,4'-Dihydroxy-3,3'-(3-methylthiopropylidene)dicoumarin | — | 207 |
271 | 1-(3,4-Dihydroxyphenyl)-2-ethylaminopropan-1-ol and its salts | 293 | 136 |
272 | 1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol | 417, 420 | 17 |
273 | Diisopropanolamine | (110, 640) | 411 |
274 | 5,5'-Di-isopropyl-2,2'-dimethylbiphenyl-4,4'-diyl dihypoiodite | 412 | 361 |
275 | Dimethoxane | 285 | 368 |
276 | 4-[2-(3,4-Dimethoxyphenyl)ethyl]-1-(2-chlorophenyl)piperazine and its salts | 438 | 141 |
277 | Dimethylamine | — | 142 |
278 | 2-Dimethylaminoethyl N-acetylglutamate | 233 | 3 |
279 | 2-Dimethylaminoethyl p-butylaminobenzoate and its salts | 687 | 63 |
280 | (+)-4-Dimethylamino-3-methyl-1,2-diphenyl-2-propionyloxybutane | 237 | 116 |
281 | 1-Dimethylaminomethyl-1-methylpropyl benzoate and its salts | 50 | 50 |
282 | 2-Dimethylaminopropiophenone and its salts | 445 | 145 |
283 | 3-(3-Dimethylaminopropylidene)-1,2:4,5-dibenzocyclohepta-1,4-diene and its salts | 42 | 146 |
284 | 1,1-Dimethylbiguanide and its salts | 447 | 147 |
285 | 2,6-Dimethyl-1,3-dioxan-4-yl acetate | 275 | 368 |
286 | Dimethylformamide | — | 355 |
287 | 1,5-Dimethylhexylamine and its salts | 34, 523 | 28 |
288 | 1,3-Dimethylpentylamine and its salts | 35, 471 | 30 |
289 | Dimethyl sulfoxide (INN) | — | 338 |
290 | Dimevamide (INN) and its salts | 297 | 153 |
291 | Dinitrophenol isomers | — | 151 |
292 | Dioxane | — | 343 |
293 | Dioxethedrin (INN) and its salts | 271 | 136 |
294 | 2,5-Dioxo-3,3-diethyl-5-methylpiperidine and its salts | 483 | 133 |
295 | Diphenhydramine (INN) and its salts | 81 | 339 |
296 | Diphenoxylate hydrochloride (INNM) | 220 | 80 |
297 | 2,2-Diphenyl-4-dimethylaminovaleramide and its salts | 290 | 153 |
298 | 5,5-Diphenyl-4-imidazolidone | — | 160 |
299 | 4-Diphenylmethoxy-1-methylpiperidine and its salts | 305 | 154 |
300 | 3-Diphenylmethoxytropane and its salts | 76 | 158 |
301 | 1-Diphenylmethyl-4-methylpiperazine and its salts | 222 | 159 |
302 | 1,2-Diphenyl-4-(2-phenylsulphinylethyl)-pyrazolidine-3,5-dione | 661 | 155 |
303 | α,α-Diphenyl-2-piperidinemethanol and its salts | 597 | 285 |
304 | α,α-Diphenyl-4-piperidinemethanol and its salts | 66 | 286 |
305 | Diphenylpyraline (INN) and its salts | 299 | 154 |
306 | 2,5-Dipropoxy-3,6-bis(ethyleneimino)-1,4-benzoquinone | 409 | 152 |
307 | 4-Dipropylsulphamoylbenzoic acid | 606 | 161 |
308 | Disulfiram (INN) | 699, 710 | 162 |
309 | Dithio-2,2'-bis(pyridine 1-oxide) 1,1' (additive with trihydrated magnesium sulphate) | 625 | 396 |
310 | Doxylamine (INN) and its salts | 576 | 176 |
311 | Emetine, its salts and derivatives | — | 163 |
312 | Endrin (ISO) | 372 | 196 |
313 | Ephedrine and its salts | — | 164 |
314 | Epinephrine (INN) | 14, 269 | 14 |
315 | 1,2-Epoxybutane | — | 400 |
316 | Ergocalciferol (INN) | 139, (759) | 335 |
317 | Ergot and its alkaloids | 193 | 98 |
318 | Eserine and its salts | 586 | 166 |
319 | Ethionamide (INN) | 335 | 319 |
320 | Ethoheptazine (INN) and its salts | 476 | 173 |
321 | Ethopropazine and its salts | (558) | 320 |
322 | 4-Ethoxyphenol | (390) | 178 |
323 | 4-Ethoxy-m-phenylenediamine and its salts | — | 406 |
324 | 2-Ethylamino-5-phenyloxazolin-4-one | 344 | 180 |
325 | Ethyl bis(4-hydroxycoumarinyl)acetate and salts of the acid | 326 | 204 |
326 | Ethyl bis(4-hydroxy-2-oxo-1-benzopyran-3-yl)acetate and salts of the acid | 325 | 204 |
327 | Ethyl chloride | 167 | 96 |
328 | Ethyl 1,3-dimethyl-4-phenylazepane-4-carboxylate and its salts | 446 | 171 |
329 | Ethylene dichloride | (248) | 125 |
330 | Ethylene oxide | — | 182 |
331 | 2-Ethyl-2,3-epoxyhexamide and its derivatives | 528 | 165 |
332 | Ethyl p-fluorophenyl sulphone | 347 | 189 |
333 | Ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate and its salts | 530 | 172 |
334 | Ethylidene dichloride | (248) | 125 |
335 | 3-Ethylisothionicotinamide | 319 | 319 |
336 | 3-Ethyl-3-methylglutarimide and its salts | 71, 337 | 183 |
337 | 4-Ethyl-4-methylpiperidine-2,6-dione and its salts | 71, 336 | 183 |
338 | 2-Ethyl-3-methylvaleramide | 753 | 184 |
339 | Ethylphenacemide | 553, 565 | 272 |
340 | 2-Ethyl-2-phenylglutarimide and its salts | 361 | 181 |
341 | 3'-Ethyl-5',6',7',8'-tetrahydro-5',5',8',8'-tetramethyl-2'-acetonaphthone | 9 | 362 |
342 | Ethyl urocanate | (405) | 418 |
343 | Fenadiazole (INN) | 526 | 208 |
344 | Fenozolone (INN) | 324 | 180 |
345 | Fenyramidol (INN) | 575, 579 | 274 |
346 | Fluanisone (INN) | 350 | 187 |
347 | Fluoresone (INN) | 332 | 189 |
348 | 4'-Fluoro-4-[4-hydroxy-4-(α,α,α-trifluoro-m-tolyl)piperino]butyrophenone | 738 | 188 |
349 | 6-Fluoro-16-methyl-11β,17α,21-trihydroxypregna-1,4-diene-3,20-dione | 533 | 186 |
350 | 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]butan-1-one | 346 | 187 |
351 | 5-Fluoropyrimidine-2,4-dione | 352 | 190 |
352 | Fluorouracil (INN) | 351 | 190 |
353 | Fluphenazine (INN) | (558) | 320 |
354 | Furazolidone (INN) | 511 | 252 |
355 | Furfuryltrimethylammonium salts | 357 | 192 |
356 | Furocoumarins (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | 98, 462, 620, 743 | 358 |
357 | Furtrethonium iodide (INN) | (355) | 192 |
358 | Galantamine (INN) | — | 193 |
359 | Gallamine triethiodide (INN) | 516 | 329 |
360 | Glucocorticoids | 100 | 300 |
361 | Glutethimide (INN) and its salts | 340 | 181 |
362 | Glycerol trinitrate | 512, 612 | 253 |
363 | Glycyclamide (INN) | 227 | 100 |
364 | Gold salts | — | 296 |
365 | Guaifenesin (INN) | 459 | 230 |
366 | Guanethidine (INN) and its salts | 367 | 259 |
367 | N-(2-Guanidinoethyl)azocane and its salts | 366 | 259 |
368 | Haloperidol (INN) | 173 | 185 |
369 | HCH (ISO) (gamma-HCH) | 102, 371, 428 | 195 |
370 | HETP | 377 | 316 |
371 | 1,2,3,4,5,6-Hexachlorocyclohexane | 102, 369, 428 | 195 |
372 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-6,7-epoxy-1,4,4a,5,6,7,8,8a-octahydro-1,4:5,8-dimethanonaphthalene | 312 | 196 |
373 | Hexachloroethane | — | 197 |
374 | 3,3',4,4',6,6'-Hexachloro-2,2'-methylenediphenol | 375 | 371 |
375 | Hexachlorophene (INN) | 374 | 371 |
376 | (1R,4S,5R,8S)-1,2,3,4,10,10-Hexachloro-1,4,4a,5,8,8a-hexahydro-1,4:5,8-dimethanonaphthalene | 415 | 198 |
377 | Hexaethyl tetraphosphate | 370 | 316 |
378 | (1R,2S)-Hexahydro-1,2-dimethyl-3,6-epoxyphthalic anhydride | 141 | 70 |
379 | (3S,5aR,9bS)-3,3a,4,5,5a,9b-Hexahydro-3,5a,9-trimethylnaphtho[1,2-b]furan-2,8-dione | 636 | 217 |
380 | Hexamethonium bromide (INN) | (381) | 124 |
381 | N,N'-Hexamethylenebis(trimethylammonium) salts | 380 | 124 |
382 | Hexapropymate (INN) | 616 | 115 |
383 | Hydrastine, hydrastinine and their salts | — | 199 |
384 | Hydrazides and their salts | — | 200 |
385 | Hydrazine, its derivatives and their salts | — | 201 |
386 | 2-Hydrazino-octane and its salts | 521 | 202 |
387 | Hydrocyanic acid and its salts | 389, 408, 601, 642 | 111 |
388 | Hydrofluoric acid, its normal salts, complexes and hydrofluorides (except those listed in Part I of Schedule 2) | — | 191 |
389 | Hydrogen cyanide and its salts | 387, 408, 601, 642 | 111 |
390 | Hydroquinone monobenzyl, monoethyl and monomethyl ethers | 96, 322, 458, 487 | 178 |
391 | 7-[2-Hydroxy-3-(2-hydroxyethyl-N-methylamino)propyl]theophylline | 762 | 135 |
392 | [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid and its salts | 739 | 5 |
393 | 3-[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propionic acid and its salts | 713 | 9 |
394 | 2-Hydroxy-3-(2-methoxyphenyl)propyl carbamate | 450 | 205 |
395 | 1-Hydroxymethyl-1-cyclohexylacetic acid, sodium salt | 643 | 114 |
396 | 4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]coumarin | 1 | 254 |
397 | 8-Hydroxy-5-nitroquinoline and its salts | 515 | 209 |
398 | 4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin and its salts | 3, 760 | 203 |
399 | 11α-Hydroxypregn-4-ene-3,20-dione and its esters | — | 385 |
400 | Hydroxy-8-quinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 2 | 114, 531, 630 | 395 |
401 | Hydroxyzine (INN) | 171 | 240 |
402 | Hyoscine, its salts and derivatives | 638 | 295 |
403 | Hyoscyamine, its salts and derivatives | — | 210 |
404 | Hyoscyamus niger L.(leaves, seeds, powder and galenical preparations) | — | 211 |
405 | 3-Imidazol-4-ylacrylic acid and its ethyl ester | 342, 751 | 418 |
406 | 2-Imino-5-phenyloxazolidin-4-one and its salts | 538 | 212 |
407 | Imperatorin | 465 | 34 |
408 | Inorganic cyanides | (387, 389) 601, 642 | 111 |
409 | Inproquone (INN) | 306 | 152 |
410 | Intracaine and its salts | 258, 536 | 179 |
411 | Iodine | — | 213 |
412 | Iodothymol | 274 | 361 |
413 | Ipecacuanha (Cephaelis ipecacuanha Brot. and related species) (roots, powder and galenical preparations) | — | 215 |
414 | Isocarboxazid (INN) | 93 | 52 |
415 | Isodrin | 376 | 198 |
416 | Isometheptene (INN) and its salts | 463 | 228 |
417 | Isoprenaline (INN) | 272, 420 | 17 |
418 | Isopropamide iodide (INN) | (145) | 156 |
419 | (2-Isopropylpent-4-enoyl)urea | 60 | 216 |
420 | Isoproterenol | 272, 417 | 17 |
421 | Isosorbide dinitrate (INN) | 244 | 148 |
422 | Juniperus sabina L. (leaves, essential oil and galenical preparations) | — | 294 |
423 | Laurel oil | 424 | 359 |
424 | Laurus nobilis L. (oil from seeds) | 423 | 359 |
425 | Lead and its compounds (except lead acetate subject to the restrictions laid down in entry number 55 in Part I of Schedule 2) | — | 289 |
426 | Levophacetoperane and its salts | 594 | 284 |
427 | Lidocaine (INN) (Lignocaine) | — | 399 |
428 | Lindane | 102, 369, 371 | 195 |
429 | Lobelia inflata L. and its galenical preparations | — | 218 |
430 | Lobeline (INN) and its salts | 112 | 219 |
431 | LSD | (433, 434) | 127 |
432 | Lupinidine and its salts | 648 | 299 |
433 | Lysergic acid diethylamide and its salts | 431, 434 | 127 |
434 | Lysergide (INN) and its salts | 431, 433 | 127 |
435 | Malononitrile | — | 149 |
436 | Mannomustine (INN) and its salts | 104 | 89 |
437 | Mecamylamine (INN) | 698 | 229 |
438 | Mefeclorazine (INN) and its salts | 276 | 141 |
439 | Mephenesin (INN) and its esters | 718 | 322 |
440 | Meprobamate (INN) | 481 | 236 |
441 | Mercury and its compounds (except those listed in Part I of Schedule 4) | — | 221 |
442 | Mescaline and its salts | 740 | 222 |
443 | Metabromsalan (INN) | (246) | 351 |
444 | Metaldehyde | 600 | 223 |
445 | Metamfepramone (INN) and its salts | 282 | 145 |
446 | Metethoheptazine (INN) and its salts | 328 | 171 |
447 | Metformin (INN) and its salts | 284 | 147 |
448 | Methapyrilene (INN) and its salts | 624 | 144 |
449 | Metheptazine (INN) and its salts | 468 | 174 |
450 | Methocarbamol (INN) | 394 | 205 |
451 | Methohexitone and its salts | (69) | 220 |
452 | Methotrexate (INN) | 33 | 6 |
453 | 2-[4-Methoxybenzyl-N-(2-pyridyl)amino]-ethyldimethylamine maleate | 622 | 346 |
454 | 1-Methoxy-2,2-bis(4-hydroxy-3-coumarinyl)ethane | 215 | 225 |
455 | 1-Methoxy-2,4-diaminobenzene and its salts | 239, 461 | 376 |
456 | 1-Methoxy-2,5-diaminobenzene and its salts | 240, 460 | 377 |
457 | (+)-3-Methoxy-N-methylmorphinan and its salts | 236 | 226 |
458 | 4-Methoxyphenol | (390) | 178 |
459 | 3-(2-Methoxyphenoxy)propane-1,2-diol | 365 | 230 |
460 | 2-Methoxy-p-phenylenediamine and its salts | 240, 456 | 377 |
461 | 4-Methoxy-m-phenylenediamine and its salts | 239, 455 | 376 |
462 | Methoxypsoralens (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
463 | 6-Methylamino-2-methylhept-2-ene and its salts | 416 | 228 |
464 | 2-Methyl-1,2-bis(3-pyridyl)propan-1-one | 484 | 292 |
465 | 9-(3-Methylbut-2-enyloxy)furo-[3,2-g]chromen-7-one | 407 | 34 |
466 | 2-Methyl-6-chloroanilide of n-butylaminoacetic acid and its salts | 125 | 90 |
467 | 1-Methyl-2,4-diaminobenzene and its salts | 477 | 364 |
468 | Methyl 1,2-dimethyl-4-phenylazepane-4-carboxylate and its salts | 449 | 174 |
469 | 3,3-Methylenebis-(4-hydroxycoumarin) | 252, 253 | 231 |
470 | 2-Methylheptylamine and its salts | — | 227 |
471 | 4-Methyl-2-hexylamine and its salts | 35, 288 | 30 |
472 | 1-Methylimidazole-2-thiol | 474, 704 | 233 |
473 | N-N'-[(Methylimino)diethylene]bis-(ethyldimethylammonium) salts | 67 | 121 |
474 | 1-Methyl-2-mercaptoimidazole | 472, 704 | 233 |
475 | Methylphenidate (INN) and its salts | 572 | 175 |
476 | 1-Methyl-4-phenyl-4-carbethoxyhexa-methyleneimine and its salts | 320 | 173 |
477 | 4-Methyl-m-phenylenediamine and its salts | 467 | 364 |
478 | 2-Methyl-m-phenylenediamine | — | 413 |
479 | 3-Methyl-2-phenylmorpholine, its derivatives and salts | 555 | 232 |
480 | 2-Methyl-2-propyl-1-isopropylcarbamoyloxy-3-carbamoyloxypropane | 151 | 235 |
481 | 2-Methyl-2-propyltrimethylene dicarbamate | 440 | 236 |
482 | N-Methyl-1,2,5,6-tetrahydro-3-nicotinic acid methyl ester | 61 | 238 |
483 | Methyprylon (INN) and its salts | 294 | 133 |
484 | Metyrapone (INN) | 464 | 292 |
485 | Minoxidil (INN), its salts and derivatives | 596 | 372 |
486 | Mofebutazone (INN) | 133 | 64 |
487 | Monobenzone (INN) | 96, (390) | 178 |
488 | Morpholine and its salts | — | 344 |
489 | Musk ambrette | 132 | 414 |
490 | Mustine and its salts | 106, 160 | 87 |
491 | Mustine N-oxide and its salts | 107 | 86 |
492 | Nalorphine (INN), its salts and ethers | 21 | 20 |
493 | Naphazoline (INN) and its salts | 499 | 244 |
494 | 2-Naphthol | 495 | 241 |
495 | β-Naphthol | 494 | 241 |
496 | 1- and 2-Naphthylamines and their salts | 497 | 242 |
497 | α- and β-Naphthylamines and their salts | 496 | 242 |
498 | 3-(1-Naphthyl)-4-hydroxycoumarin | — | 243 |
499 | 2-(1-Naphthylmethyl)-2-imidazoline and its salts | 493 | 244 |
500 | Narcotics, natural and synthetic: All substances listed in Tables I and II of the Single Convention on Narcotic Drugs 1961 (Treaty Series No. 34 (1965), Cmnd. 2631) | — | 306 |
501 | Narcotine and its salts | 519 | 258 |
502 | Neodymium and its salts | — | 309 |
503 | Neostigmine and its salts | — | 245 |
504 | Nicotine and its salts | — | 246 |
505 | Nitrites, inorganic (except sodium nitrite) | — | 248 |
506 | Nitrobenzene | — | 249 |
507 | Nitrocresols and their alkali metal salts | — | 250 |
508 | Nitroderivatives of carbazole | 146 | 72 |
509 | Nitrofurantoin (INN) | 510 | 251 |
510 | N-(5-Nitro-2-furfurylidene)-1-aminohydantoin | 509 | 251 |
511 | 3-(5-Nitrofurfurylideneamino)oxazolidin-2-one | 354 | 252 |
512 | Nitroglycerine | 362, 612 | 253 |
513 | Nitrosamines | — | 410 |
514 | Nitrostilbenes, their homologues and derivatives | — | 256 |
515 | Nitroxoline (INN) and its salts | 397 | 209 |
516 | N,N,N,N',N',N',N",N",N"-Nonaethyl-2,2',2"-(benzene-1,2,3-triyltrioxy)-tris(ethanaminium) triiodide | 359 | 329 |
517 | Noradrenaline and its salts | 32, 518 | 257 |
518 | Norepinephrine (INN) and its salts | 32, 517 | 257 |
519 | Noscapine (INN) and its salts | 501 | 258 |
520 | Nux vomica and its preparations | (658) | 305 |
521 | Octamoxin (INN) and its salts | 386 | 202 |
522 | Octamylamine (INN) and its salts | — | 267 |
523 | Octodrine (INN) and its salts | 34, 287 | 28 |
524 | Oestrogens | — | 260 |
525 | Oleandrin | — | 261 |
526 | 2-(1,3,4-Oxadiazol-2-yl)phenol | 343 | 208 |
527 | [Oxalylbis(iminoethylene)]bis[(o-chlorobenzyl)diethylammonium] salts | 24 | 132 |
528 | Oxanamide (INN) and its derivatives | 331 | 165 |
529 | 2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine and its salts | 685 | 139 |
530 | Oxpheneridine (INN) and its salts | 333 | 172 |
531 | Oxyquinoline and its sulphate, except for the uses provided for in entry number 51 in Part I of Schedule 2 | 114, 400, 630 | 395 |
532 | Padimate A | 47 | 381 |
533 | Paramethasone (INN) | 349 | 186 |
534 | Paraoxon | 262 | 170 |
535 | Parathion (ISO) | 263 | 131 |
536 | Parethoxycaine (INN) and its salts | 258, 410 | 179 |
537 | Pelletierine and its salts | 595 | 263 |
538 | Pemoline (INN) and its salts | 406 | 212 |
539 | Pentachloroethane | — | 264 |
540 | Pentaerythritol chloral | 549 | 266 |
541 | Pentaerythritol tetranitrate | 542, 548 | 265 |
542 | Pentaerythrityl tetranitrate (INN) | 541, 548 | 265 |
543 | Pentamethonium bromide (INN) | (544) | 120 |
544 | N,N'-Pentamethylenebis(trimethyl-ammonium) salts | 543 | 120 |
545 | Pentobarbitone and its salts | (69) | 220 |
546 | Perchloroethylene | 689 | 314 |
547 | Perphenazine (INN) and its salts | (558) | 320 |
548 | PETN | 541, 542 | 265 |
549 | Petrichloral (INN) | 540 | 266 |
550 | Phenacemide (INN) | 561 | 269 |
551 | Phenaglycodol (INN) | 174 | 95 |
552 | Phenetamine | 225 | 112 |
553 | Pheneturide (INN) | 339, 565 | 272 |
554 | Phenindone (INN) | 571 | 271 |
555 | Phenmetrazine (INN), its derivatives and salts | 479 | 232 |
556 | Phenobarbitone and its salts | (69) | 220 |
557 | Phenolphthalein (INN) | 113 | 417 |
558 | Phenothiazine (INN) and its compounds | various | 320 |
559 | Phenprobamate (INN) | 573 | 71 |
560 | Phenprocoumon (INN) | 574 | 273 |
561 | N-Phenylacetylurea | 550 | 269 |
562 | 4-Phenylazophenylene-1,3-diamine citrate hydrochloride | 190 | 81 |
563 | Phenylbutazone (INN) | 131 | 67 |
564 | 4-Phenylbut-3-en-2-one | 94 | 356 |
565 | (2-Phenylbutyryl)urea | 339, 553 | 272 |
566 | N-[2-(α-Phenyl-p-chlorobenzyl)-ethyl]morpholine | 264 | 270 |
567 | 1-Phenylcyclopentanecarboxylic acid diethylaminoethyl ester and its salts | 144 | 169 |
568 | 2-Phenylcyclopropylamine (trans-form) and its salts | 719 | 324 |
569 | 1-Phenyl-2,3-dimethyl-4-isopropylpyrazol-5-one | 617 | 138 |
570 | o-Phenylenediamine and its salts | 241 | 363 |
571 | 2-Phenylindan-1,3-dione | 554 | 271 |
572 | α-Phenyl-2-piperidineacetic acid methyl ester and its salts | 475 | 175 |
573 | 3-Phenylpropyl carbamate | 559 | 71 |
574 | 3-(α-Phenylpropyl)-4-hydroxycoumarin | 560 | 273 |
575 | 1-Phenyl-2-(2-pyridylamino)ethanol | 345, 579 | 274 |
576 | 2-[1-Phenyl-1-(2-pyridyl)ethoxy]-ethyldimethylamine and its salts | 310 | 176 |
577 | 2-Phenylquinoline-4-carboxylic acid, its salts and derivatives and salts of those derivatives | 192 | 8 |
578 | 6-Phenyl-2,4,7-triaminopteridine and its salts | 722 | 275 |
579 | Phenyramidol | 345, 575 | 274 |
580 | Phosphides, metal | — | 279 |
581 | Phosphorus | — | 279 |
582 | 4-Phosphoryloxy-N,N-dimethyltryptamine | 619 | 278 |
583 | 3-Phthalimidopiperidine-2,6-dione and its salts | 701 | 280 |
584 | Phthalylsulphathiazole (INN) and its salts | (675) | 307 |
585 | Physostigma venenosum Balf. | 138 | 281 |
586 | Physostigmine and its salts | 318 | 166 |
587 | Phytolacca Spp and their preparations | — | 374 |
588 | Picric acid | 742 | 268 |
589 | Picrotoxin | 197 | 282 |
590 | Pilocarpine and its salts | — | 283 |
591 | Pilocarpus jaborandi Holmes and its galenical preparations | — | 311 |
592 | Pipazetate (INN) and its salts | 593 | 118 |
593 | 2-(2-Piperidinoethoxy)ethyl 10-thia-1,9-diazaanthracene-9-carboxylate and its salts | 592 | 118 |
594 | α-Piperidin-2-ylbenzyl acetate, laevorotatory threo-form and its salts | 426 | 284 |
595 | 1-(2-Piperidyl)propan-2-one and its salts | 537 | 263 |
596 | 6-(Piperidinyl)-2,4-pyrimidinediamine 3-oxide, its salts and derivatives | 485 | 372 |
597 | Pipradrol (INN) and its salts | 303 | 285 |
598 | Piprocurarium iodide (INN) | 255 | 137 |
599 | Poldine metilsulfate (INN) (Poldine methylsulphate) | 85 | 239 |
600 | Polyacetaldehyde | 444 | 223 |
601 | Potassium cyanide | (387, 389, 408) | 111 |
602 | Potassium nitroferricyanide | (15), 603 | 255 |
603 | Potassium nitroprusside | (15), 602 | 255 |
604 | Pramocaine (INN) | 605 | 405 |
605 | Pramoxine | 604 | 405 |
606 | Probenecid (INN) | 307 | 161 |
607 | Procainamide (INN), its salts and derivatives | 29 | 25 |
608 | Prochlorperazine (INN) and its salts | (558) | 320 |
609 | Progestogens | — | 194 |
610 | Promazine (INN) and its salts | (558) | 320 |
611 | Promethazine (INN) and its salts | (558) | 320 |
612 | Propane-1,2,3-triyl trinitrate | 362, 512 | 253 |
613 | Propatylnitrate (INN) | 111 | 206 |
614 | 1-Propyl-3-(4-chlorobenzenesulphonyl)urea | 182 | 79 |
615 | 2-Propylpiperidine | 212 | 290 |
616 | 1-(2-Propynyl)cyclohexyl carbamate | 382 | 115 |
617 | Propyphenazone (INN) | 569 | 138 |
618 | Prunus laurocerasus L. | 157 | 291 |
619 | Psilocybine (INN) | 582 | 278 |
620 | Psoralen (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
621 | Pyrethrum album L. and its galenical preparations | — | 345 |
622 | Pyrianisamine maleate | 453 | 346 |
623 | Pyribenzamine | 97, 745 | 347 |
624 | 2-(N-2-Pyridyl-N-2-thienylamino)ethyl-dimethylamine and its salts | 448 | 144 |
625 | Pyrithione disulphide+magnesium sulphate | 309 | 396 |
626 | Pyrithione sodium (INNM) | — | 369 |
627 | Pyrocatechol | 79, 153 | 408 |
628 | Pyrogallol | — | 409 |
629 | Quinalbarbitone and its salts | (69) | 220 |
630 | Quinolin-8-ol except for the uses provided for in entry number 51 in Part I of Schedule 2 | (400, 531) | 395 |
631 | Radioactive substances (except substances which are radioactive naturally or by reason of contamination from the environment, which have not been enriched for manufacturing purposes, and of which the concentration complies with Council Directive No. 76/579/Euratom(1)) | — | 293 |
632 | Rauwolfia serpentina alkaloids and their salts | 633 | 15 |
633 | Reserpine (INN) and its salts | (632) | 15 |
634 | Retinoic acid and its salts | 721, 758 | 375 |
635 | Safrole (except natural content of essences in cases where the concentration of such safrole in the cosmetic product does not exceed— (a) in the case of oral hygiene or dental products other than toothpaste intended specifically for children, 50 mg/kg; or (b) in the case of products other than oral hygiene or dental products, 100 mg/kg) | — | 360 |
636 | α-Santonin | 379 | 214 |
637 | Schoenocaulon officinale Lind. (seeds and galenical preparations) | — | 332 |
638 | Scopolamine, its salts and derivatives | 402 | 295 |
639 | Secbutobarbitone and its salts | (69) | 220 |
640 | Secondary dialkanolamines | 110, 254, 273 | 411 |
641 | Selenium and its compounds except when permitted under the restrictions laid down in Part I of Schedule 2 | — | 297 |
642 | Sodium cyanide | (387, 389, 408) | 111 |
643 | Sodium hexacyclonate (INN) | 395 | 114 |
644 | Sodium nitroferricyanide | (15), 645 | 255 |
645 | Sodium nitroprusside | (15), 644 | 255 |
646 | Solanum nigrum L. and its galenical preparations | — | 298 |
647 | Spanish Fly | 140 | 69 |
648 | Sparteine (INN) and its salts | 432 | 299 |
649 | Spironolactone (INN) | 10 | 4 |
650 | Squill and its preparations | 750 | 330 |
651 | Stramonium and its preparations | 231 | 301 |
652 | Strontium lactate | — | 402 |
653 | Strontium nitrate | — | 403 |
654 | Strontium polycarboxylate | — | 404 |
655 | Strophanthines and their aglucones and their respective derivatives | — | 302 |
656 | Strophanthus species and their galenical preparations | — | 303 |
657 | Strychnine and its salts | — | 304 |
658 | Strychnos species and their galenical preparations | 520 | 305 |
659 | Succinonitrile | — | 150 |
660 | Succinylsulphathiazole and its salts | (675) | 307 |
661 | Sulfinpyrazone (INN) | 302 | 155 |
662 | Sulphacetamide and its salts | (675) | 307 |
663 | Sulphadiazine and its salts | (675) | 307 |
664 | Sulphadimethoxine and its salts | (675) | 307 |
665 | Sulphadimidine and its salts | (675) | 307 |
666 | Sulphafurazole and its salts | (675) | 307 |
667 | Sulphaguanidine and its salts | (675) | 307 |
668 | Sulphamethizole and its salts | (675) | 307 |
669 | Sulphamethoxazole and its salts | (675) | 307 |
670 | Sulphamethoxydiazine and its salts | (675) | 307 |
671 | Sulphamethoxypyridazine and its salts | (675) | 307 |
672 | Sulphanilamide and its salts | (675) | 307 |
673 | Sulphapyridine and its salts | (675) | 307 |
674 | Sulphathiazole and its salts | (675) | 307 |
675 | Sulphonamides (sulphanilamide and its derivatives obtained by substitution of one or more H-atoms of the −NH2 groups) and their salts | 584, 660, 662–674 | 307 |
676 | Sulthiame | 677, 696 | 308 |
677 | Sultiame (INN) | 676, 696 | 308 |
678 | Sympathomimetic amines acting on the central nervous system: any substance contained in the first list of medicaments which are subject to medical prescription and are referred to in resolution AP (69) 2 of the Council of Europe | 44 | 21 |
679 | Tefazoline (INN) and its salts | 695 | 237 |
680 | Tellurium and its compounds | — | 312 |
681 | TEPP (ISO) | 693 | 276 |
682 | 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline and its salts | 764 | 313 |
683 | 4-tert-Butylphenol | — | 340 |
684 | 4-tert-Butylpyrocatechol | — | 341 |
685 | Tetrabenazine (INN) and its salts | 529 | 139 |
686 | Tetrabromosalicylanilides | — | 350 |
687 | Tetracaine (INN) and its salts | 279 | 63 |
688 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin | — | 367 |
689 | Tetrachloroethylene | 546 | 314 |
690 | Tetrachloromethane | 148 | 315 |
691 | Tetrachlorosalicylanilides | — | 348 |
692 | Tetraethylammonium bromide | 700 | 61 |
693 | Tetraethyl pyrophosphate | 681 | 276 |
694 | (R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol and its salts | 59 | 42 |
695 | 2-(5,6,7,8-Tetrahydro-1-naphthylmethyl)-2-imidazoline and its salts | 679 | 237 |
696 | 4-(Tetrahydro-2H-1,2-thiazin-2-yl)-benzenesulphonamide S,S-dioxide | 676, 677 | 308 |
697 | Tetrahydrozoline and its salts | — | 394 |
698 | N,2,3,3-Tetramethyl-2-norcamphanamine | 437 | 229 |
699 | Tetramethylthiuram disulphide | 710 | 162 |
700 | Tetrylammonium bromide (INN) | 692 | 61 |
701 | Thalidomide (INN) and its salts | 583 | 280 |
702 | Thallium and its compounds | — | 317 |
703 | Thevetia neriifolia Juss., glycoside extract | — | 318 |
704 | Thiamazole (INN) | 472, 474 | 233 |
705 | 2,2'-Thiobis(4,6-dichlorophenol) | 115 | 352 |
706 | Thiopentone and its salts | (69) | 220 |
707 | Thioridazine (INN) and its salts | (558) | 320 |
708 | Thiotepa (INN) | 723 | 310 |
709 | Thiourea and its derivatives (except those listed in Part I of Schedule 2) | — | 321 |
710 | Thiram (ISO) | 699 | 162 |
711 | Thiuram disulphides | — | 354 |
712 | Thiuram monosulphides | — | 353 |
713 | Thyropropic acid (INN) and its salts | 393 | 9 |
714 | Tolboxane (INN) | 717 | 177 |
715 | Tolbutamide (INN) | 134 | 65 |
716 | Toluidines, their isomers, salts and halogenated and sulphonated derivatives | 40 | 32 |
717 | p-Tolylboric acid ester of 2-methyl-2-propylpropane-1,3-diol | 714 | 177 |
718 | 3-o-Tolyloxypropane-1,2-diol | (439) | 322 |
719 | Tranylcypromine (INN) and its salts | 568 | 324 |
720 | Tretamine (INN) | 724 | 328 |
721 | Tretinoin (INN) and its salts | 634, 758 | 375 |
722 | Triamterene (INN) and its salts | 578 | 275 |
723 | Tri(aziridin-1-yl)phosphine sulphide | 708 | 310 |
724 | 2,4,6-Tri(aziridin-1-yl)-1,3-triazine | 720 | 328 |
725 | 2,2,2-Tribromoethanol | (726) | 326 |
726 | Tribromoethyl alcohol | 725 | 326 |
727 | Tribromsalan (INN) | 728 | 373 |
728 | 3,4',5-Tribromosalicylanilide | 727 | 373 |
729 | Trichlormethine (INN) and its salts | 746 | 327 |
730 | Trichloroacetic acid | — | 10 |
731 | 1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane | 195, 232 | 123 |
732 | 2,2,2-Trichloroethane-1,1-diol | 158 | 77 |
733 | Trichloromethane | 168 | 366 |
734 | N-(Trichloromethylthio)cyclohex-4-ene-1,2-dicarboximide | 142 | 370 |
735 | Trichloronitromethane | 178 | 325 |
736 | Tricresyl phosphate | 747 | 277 |
737 | Trifluoperazine (INN) and its salts | (558) | 320 |
738 | Trifluperidol (INN) | 348 | 188 |
739 | 3,3',5-Triiodothyroacetic acid and its salts | 392 | 5 |
740 | 3,4,5-Trimethoxyphenethylamine and its salts | 442 | 222 |
741 | 2,2,6-Trimethyl-4-piperidyl benzoate and its salts | 75 | 51 |
742 | 2,4,6-Trinitrophenol | 588 | 268 |
743 | Trioxysalen (INN) (except natural content of essences). In sun protection and in bronzing products, furocoumarins content shall be below 1 mg/kg | (356) | 358 |
744 | Triparanol (INN) | 172 | 92 |
745 | Tripelennamine (INN) | 97, 623 | 347 |
746 | Tris(2-chloroethyl)amine | 729 | 327 |
747 | Tritolyl phosphate | 736 | 277 |
748 | Tuaminoheptane (INN), its isomers and salts | 30 | 27 |
749 | Tyrothricin (INN) | — | 392 |
750 | Urginea scilla Stern. and its galenical preparations | 650 | 330 |
751 | Urocanic acid | (405) | 418 |
752 | Vaccines, toxins and serums listed in the Annex to Council Directive No. 75/319/EEC(2) | — | 323 |
753 | Valnoctamide (INN) | 338 | 184 |
754 | Veratrine, its salts and galenical preparations | — | 331 |
755 | Veratrum spp and their preparations | — | 333 |
756 | Vinyl chloride monomer | — | 334 |
757 | Vinylidene chloride | (7, 249) | 126 |
758 | Vitamin A acid and its salts | 634, 721 | 375 |
759 | Vitamins D2 and D3 | 139, 187, 316 | 335 |
760 | Warfarin (ISO) and its salts | 3, 398 | 203 |
761 | Xanthates | 16 | 336 |
762 | Xanthinol | 391 | 135 |
763 | Xylidines, their isomers, salts and halogenated and sulphonated derivatives | 41 | 33 |
764 | Xylometazoline (INN) and its salts | 682 | 313 |
765 | Yohimbine and its salts | — | 337 |
766 | Zirconium and its compounds (except aluminium zirconium chloride hydroxide complexes and aluminium zirconium chloride hydroxide glycine complexes under the conditions laid down in Part I of Schedule 2 and zirconium lakes, salts and pigments prepared from those colouring agents identified in column 1 of Part I of Schedule 3 by “*” immediately after the name or colour index number) | — | 391 |
767 | Zoxazolamine (INN) | 28 | 24 |
Regulations 4(2), 5(1) and 6(2)
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in columns 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used except for the purposes or contained other than in the types of product specified in column 3. The concentration of the substance in a product may not exceed the limit specified in column 4: where the names of two or more substances are mentioned in a single item as set out in column 2 and a product contains more than one of those substances, the limit specified in column 4 is the limit for all of those substances taken together; and where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 5. In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
Names which appear in square brackets in column 2 are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC(3).
(1) | (2) | (3) | (4) | (5) | (6) |
---|---|---|---|---|---|
Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information |
Note 1: Entry 15a is substituted with effect from the dates specified in regulation 1(6). Until then, entry number 15 in Part I of Schedule 2 to S.I. 1989/2233 continues in force. Note 2: The concentration of sodium, potassium or lithium hydroxide is expressed as percentage of sodium hydroxide. In cases of mixtures, the sum must not exceed the limits given in column (4). | |||||
1 | Boric acid | Talcum powder | 5 per cent | Not to be used in products intended for children less than three years old | Not to be used for children under three years of age |
Oral hygiene products | 0.5 per cent | — | — | ||
Other products | 3 per cent | — | — | ||
2a | Thioglycolic acid and its salts | (a) Hair waving or straightening products for general use | 8 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children |
(b) Hair waving or straightening products for professional use | 11 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. For professional use only | ||
(c) Depilatories | 5 per cent ready for use | pH 7 to 12.7 | Contains thioglycolate. Follow the instructions. Keep out of reach of children | ||
(d) Other hair-care products which are removed after application | 2 per cent ready for use | pH 7 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children | ||
The abovementioned percentages are calculated as thioglycolic acid | (a), (b), (c) and (d): The directions for use must incorporate the following:
| ||||
2b | Thioglycolic acid esters | (a) Hair waving or straightening products for general use | 8 per cent ready for use | pH 6 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children |
(b) Hair waving or straightening products for professional use | 11 per cent ready for use | pH 6 to 9.5 | Contains thioglycolate. Follow the instructions. Keep out of reach of children. For professional use only | ||
The abovementioned percentages are calculated as thioglycolic acid | (a) and (b): the directions for use must incorporate the following:
| ||||
3 | Oxalic acid, its esters and alkaline salts | Hair care products | 5 per cent | — | For professional use only |
4 | Ammonia | All purposes and products | 6 per cent calculated as NH3 | — | Contains ammonia (not required when concentration is not more than 2 per cent) |
5 | Tosylchloramide sodium (INN) [Chloramine-T] | All purposes and products | 0.2 per cent | — | — |
6 | Chlorates of alkali metals | Toothpaste | 5 per cent | — | — |
Other uses | 3 per cent | — | — | ||
7 | Dichloromethane | All purposes and products | 35 per cent (and when mixed with 1,1,1-trichloroethane, total concentration must not exceed 35 per cent) | Purity of the dichloromethane must be not less than 99.8 per cent | — |
8 | m- and p-Phenylenediamines, their N-substituted derivatives and their salts; N-substituted derivatives of o-phenylenediamines | Oxidizing colouring agents for hair-dyeing for general use | 6 per cent calculated as a free base, subject to the provision of “Combination Rule A” set out below | — | Contains phenylenediamines. Can cause an allergic reaction. Do not use to dye eyelashes or eyebrows |
Oxidizing colouring agents for hair-dyeing for professional use | 6 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains phenylenediamines. For professional use only. Can cause an allergic reaction. Wear suitable gloves | ||
9 | Methylphenylenediamines (other than 4-methyl-m-phenylenediamine and its salts), their N-substituted derivatives and their salts (Toluenediamines (other than toluene-1,3-diamine and its salts), their N-substituted derivatives and their salts) | Oxidizing colouring agents for hair-dyeing for general use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains phenylenediamines. Can cause an allergic reaction. Do not use to dye eyelashes or eyebrows. |
Oxidizing colouring agents for hair-dyeing for professional use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains phenylenediamines. For professional use only. Can cause an allergic reaction. Wear suitable gloves | ||
10 | Diaminophenols | Oxidizing colouring agents for hair-dyeing for general use | 10 per cent calculated as a free base, subject to the provisions of “Combination Rule A” set out below | — | Contains diaminophenols. Can cause allergic reaction. Do not use to dye eyelashes or eyebrows |
Oxidizing colouring agents for hair-dyeing for professional use | 10 per cent calculated as afree base, subject to the provisions of “Combination Rule A” set out below | — | Contains diaminophenols. For professional use only. Can cause allergic reaction. Wear suitable gloves | ||
11 | Dichlorophen (INN) [Dichlorophene] | All purposes and products | 0.5 per cent | — | Contains dichlorophen |
12 | Hydrogen peroxide and other compounds or mixtures that release hydrogen peroxide including hydrogen peroxide-urea (hydrogen peroxide-carbamide) and zinc peroxide | (a)Hair-care preparations (b)Skin-care preparations (c)Nail hardening preparations (d)Oral hygiene products | 12 per cent of H2O2 present or released 4 per cent of H2O2 present or released 2 per cent of H2O2 present or released 0.1 per cent of H2O2 present or released | — — — — | (a): Wear suitable gloves (a)(b)(c): Contains hydrogen peroxide. Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them — |
13 | Formaldehyde (see also Part I of Schedule 4) | Nail hardeners | 5 per cent | — | Contains formaldehyde. Protect cuticles with grease or oil. (Not required when concentration is not more than 0.05 per cent) |
14 | Hydroquinone | Oxidizing colouring agent for hair dyeing for general use | 2 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains hydroquinone. Do not use to dye eyelashes or eyebrows. Rinse eyes immediately if product comes into contact with them |
Oxidizing colouring agent for hair dyeing for professional use | 2 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains hydroquinone. For professional use only. Rinse eyes immediately if product comes into contact with them | ||
Agents for localised skin lightener | 2 per cent | — | Contains hydroquinone. Avoid contact with eyes. Apply to small areas. If irritation develops discontinue use. Do not use on children under the age of 12 | ||
15a | Potassium hydroxide and sodium hydroxide (see Note 1) | Nail cuticle solvent | 5 per cent calculated as sodium hydroxide (see Note 2) | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
Hair straightener for general use | 2 per cent calculated as sodium hydroxide (see Note 2) | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children | ||
Hair straightener for professional use | 4.5 per cent calculated as sodium hydroxide (see Note 2) | — | For professional use only. Avoid contact with eyes. Can cause blindness | ||
pH adjuster for depilatories | — | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes | ||
Other uses as pH adjuster | — | pH value not to exceed 11 | — | ||
15b | Lithium hydroxide | Hair straightener for general use | 2 per cent calculated as sodium hydroxide (see Note 2) | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
Hair straightener for professional use | 4.5 per cent calculated as sodium hydroxide (see Note 2) | — | For professional use only. Avoid contact with eyes. Can cause blindness | ||
Other uses | — | — | — | ||
15c | Calcium hydroxide | Hair straighteners containing two components: calcium hydroxide and guanidine salt | 7 per cent | — | Contains alkali. Avoid contact with eyes. Can cause blindness. Keep out of reach of children |
Other uses | — | — | — | ||
16 | α-Naphthol[1-Naphthol] | Colouring agent for hair dyeing | 0.5 per cent | — | Contains α-napthol |
17 | Sodium nitrite | Rust inhibitor | 0.2 per cent | Do not use with secondary and/or tertiary amines or other substances forming nitrosamines | — |
18 | Nitromethane | Rust inhibitor | 0.3 per cent | — | — |
19 | Phenol and its alkali salts | Soaps and shampoos | 1 per cent calculated as phenol | — | Contains phenol |
20 | ENTRY DELETED | ||||
21 | Quinine and its salts | Shampoos | 0.5 per cent calculated as quinine base | — | — |
Hair lotions | 0.2 per cent calculated as quinine base | — | — | ||
22 | Resorcinol | Oxidizing colouring agent for hair dyeing for general use | 5 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains resorcinol. Rinse hair well after application. Do not use to dye eyelashes or eyebrows. Rinse eyes immediately if product comes into contact with them |
Oxidizing colouring agent for hair dyeing for professional use | 5 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains resorcinol. For professional use only. Rinse eyes immediately if product comes into contact with them | ||
Hair lotions and shampoos | 0.5 per cent subject to the provisions of “Combination Rule B” set out below | — | Contains resorcinol | ||
23a | Alkali sulphides | Depilatories | 2 per cent calculated as sulphur | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes |
23b | Alkaline earth sulphides | Depilatories | 6 per cent calculated as sulphur | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with eyes |
24 | Water-soluble zinc salts with the exception of zinc 4-hydroxybenzenesulphonate | All purposes and products | 1 per cent calculated as zinc | — | — |
25 | Zinc 4-hydroxybenzene-sulphonate [Zinc phenolsulfonate] | Deodorants, antiperspirants and astringent lotions | 6 per cent calculated as percentage of anhydrous substance | — | Avoid contact with eyes |
26 | Ammonium monofluorophosphate | Oral hygiene products | 0.15 per cent calculated as fluorine. When mixed with other fluorine compounds the total fluorine concentration must not exceed 0.15 per cent | — | Contains ammonium monofluorophosphate |
27 | Sodium monofluorophosphate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains sodium monofluorophosphate |
28 | Potassium monofluorophosphate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains potassium monofluorophosphate |
29 | Calcium monofluorophosphate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains calcium monofluorophosphate |
30 | Calcium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains calcium fluoride |
31 | Sodium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains sodium fluoride |
32 | Potassium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains potassium fluoride |
33 | Ammonium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains ammonium fluoride |
34 | Aluminium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains aluminium fluoride |
35 | Stannous fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains stannous fluoride |
36 | Hexadecylammonium fluoride [Cetylamine hydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains hexadecylammonium fluoride |
37 | 3-(n-Hexadecyl-N-2-hydroxyethylammonio)-propylbis(2-hydroxyethyl)-ammonium difluoride [Stearyl trihydroxyethyl propylenediamine dihydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains 3-(n-hexadecyl-N-2-hydroxyethylammonio)propylbis(2-hydroxyethyl)ammonium difluoride |
38 | N,N',N'-Tris(polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride [Palmityl trihydroxyethyl propylenediamine dihydrofluoride] | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains N,N',N'-tris(polyoxyethylene)-N-hexadecylpropylenediamine dihydrofluoride |
39 | Octadecenylammonium fluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains octadecenylammonium fluoride |
40 | Sodium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains sodium fluorosilicate |
41 | Potassium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains potassium fluorosilicate |
42 | Ammonium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains ammonium fluorosilicate |
43 | Magnesium fluorosilicate | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains magnesium fluorosilicate |
44 | 1,3-Bis(hydroxymethyl)-imidazolidene-2-thione [Dimethylol ethylene thiourea] | Hair care preparations | 2 per cent | Not to be used in aerosol dispensers | Contains 1,3-bis(hydroxymethyl)imidazolidene-2-thione |
Nail care preparations | 2 per cent | pH value as applied must be less than 4 | Contains 1,3-bis(hydroxymethyl)imidazolidene-2-thione | ||
45 | Benzyl alcohol (See also Part I of Schedule 4) | Solvent, perfumes and flavourings | — | — | — |
46 | 6-Methylcoumarin | Oral hygiene products | 0.003 per cent | — | — |
47 | Nicomethanol hydrofluoride | Oral hygiene products | As for ammonium monofluorophosphate | — | Contains nicomethanol hydrofluoride |
48 | Silver nitrate | Products to dye eyelashes or eyebrows | 4 per cent | — | Contains silver nitrate. Rinse eyes immediately if product comes into contact with them |
49 | Selenium disulphide [Selenium sulfide] | Anti-dandruff shampoos | 1 per cent | — | Contains selenium disulphide. Avoid contact with eyes or damaged skin |
50 | Aluminium zirconium chloride hydroxide complexes AlxZr(OH)yClz and aluminium zirconium chloride hydroxide glycine complexes | Anti-perspirants | 20 per cent as anhydrous aluminium zirconium chloride hydroxide, 5.4 per cent as zirconium | The ratio of the number of aluminium atoms to that of zirconium atoms must be between 2 and 10 The ratio of the number of (Al+Zr) atoms to chlorine atoms must be between 0.9 and 2.1 Not to be used in aerosol dispensers (sprays) | Do not apply to irritated or damaged skin |
51 | Quinolin-8-ol and bis(8-hydroxyquinolinium sulphate) (See also Part II of this Schedule) [Oxyquinoline and Oxyquinoline sulfate] | Stabilizer for hydrogen peroxide in rinse-off hair care preparations | 0.3 per cent calculated as base | — | — |
Stabilizer for hydrogen peroxide in non rinse-off hair care preparations | 0.03 per cent calculated as base | — | — | ||
52 | Methanol | Denaturant for ethanol and isopropyl alcohol | 5 per cent calculated as a percentage of ethanol and isopropyl alcohol | — | — |
53 | Etidronic acid and its salts (1-hydroxyethylidene-diphosphonic acid and its salts) | Hair care Soap | 1.5 per cent expressed as etidronic acid 0.2 per cent expressed as etidronic acid | — — | — — |
54 | 1-Phenoxypropan-2-ol (See also Part I of Schedule 4) [Phenoxyisopropanol] | Products rinsed off after use. Prohibited in oral hygiene products | 2 per cent | — | — |
55 | Lead acetate | Only for hair dyeing | 0.6 per cent calculated as lead | — | Contains lead acetate. Keep away from children. Avoid all contact with the eyes. Wash hands after use. Do not use to dye eyelashes, eyebrows or moustaches. If irritation develops discontinue use |
56 | Magnesium fluoride | Dental hygiene products | 0.15 per cent calculated as fluorine. When mixed with other fluorine compounds the total fluorine concentration must not exceed 0.15 per cent | — | Contains magnesium fluoride |
57 | Strontium chloride hexahydrate | Toothpaste | 3.5 per cent calculated as strontium. When mixed with other permitted strontium compounds the total strontium content must not exceed 3.5 per cent | — | Contains strontium chloride. Use by children is not advisable |
58 | Strontium acetate hemihydrate | Toothpaste | 3.5 per cent calculated as strontium. When mixed with other permitted strontium products the total strontium content must not exceed 3.5 per cent | — | Contains strontium acetate. Use by children is not advisable |
59 | Talc: hydrated magnesium silicate | (a) Powdery products intended to be used for children under three years of age | — | — | (a): Keep powder away from children’s nose and mouth |
(b) other products | — | — | |||
60 | Fatty acid dialkanolamides | All purposes and products | Maximum dialkanolamine content: 0.5 per cent | Do not use with nitrosating systems. Maximum dialkanolamine content: 5 per cent (applies to raw materials). Maximum N-nitrosodialkanolamine content: 50 μ g/kg (applies to raw materials). Keep in nitrite-free containers | — |
61 | Monoalkanolamines | All purposes and products | Maximum dialkanolamine content: 0.5 per cent | Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum dialkanolamine content: 0.5 per cent (applies to raw materials). Maximum N-nitrosodialkanolamine content: 50 μ g/kg (applies to raw materials). Keep in nitrite-free containers | — |
62 | Trialkanolamines | (a)non-rinse-off (b)other products | (a)2.5 per cent | (a) (b): Do not use with nitrosating systems. Minimum purity: 99 per cent. Maximum dialkanolamine content: 0.5 per cent (applies to raw materials). Maximum N-nitrosodialkanolamine content: 50 μ g/kg (applies to raw materials). Keep in nitrite-free containers | — |
63 | Strontium hydroxide | pH-regulator in depilatory products | 3.5 per cent calculated as strontium | pH value not to exceed 12.7 | Keep out of reach of children. Avoid contact with the eyes |
64 | Strontium peroxide | Rinse-off hair care preparations for professional use | 4.5 per cent calculated as strontium in the ready-for-use preparation | All products must meet the hydrogen peroxide release requirements | Avoid contact with eyes. Rinse eyes immediately if product comes into contact with them. For professional use only. Wear suitable gloves |
(1) | (2) | (3) | (4) | (5) | (6) | (7) |
---|---|---|---|---|---|---|
Reference Number | Name of Substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information | Permitted for use until |
NOTE—There are presently no entries in this Part. Combination Rules A. Where a cosmetic product contains two or more substances to which this Combination Rule applies, the concentration in the product of each of those substances shall be such that the sum of the relevant quotients for those substances (as defined in Rule C below) shall not exceed 1. B. Where a cosmetic product contains the substances to which this Combination Rule applies, the concentration in the product of each of those substances shall be such that the sum of the relevant quotients for those substances (as defined in Rule C below) shall not exceed 2; but the concentration of each substance shall not in any event exceed the limit specified for the substance in respect of the product in column 4 above. C. The relevant quotient for each substance is the actual concentration of the substance in the product divided by the maximum concentration specified for the substance in respect of the product in Column 4 of this Schedule. | ||||||
Regulations 4(2) and 6(9)
In this Schedule the colouring agents referred to in regulation 4(2)(c) are—
(i)those identified in column 1 either by name or by colour index number (the colour index numbers being those specified in the third edition of The Colour Index published in 1971 by the Society of Dyers and Colourists);
(ii)lakes or salts of these colouring agents which do not use substances prohibited under Schedule 1.
In the case of colouring agents identified by the addition of (*) to the name or colour index number, the insoluble barium, strontium and zirconium lakes, salts and pigments of these colouring agents shall also be permitted. They must pass the test for insolubility which will be determined by the procedure laid down in Article 8 of the Directive.
Colouring agents whose number is preceded by the letter ‘E’ in accordance with the EEC Directive of 23 October 1962 on the approximation of the rules of member States concerning foodstuffs and colouring matter(5), as amended(6), adapted(7) and replaced in part(8) must fulfil the purity requirements laid down in those Directives.
In column 3 of this Schedule, the entry “X” in a sub-column means that the colouring agent must not be used other than as follows—
Sub-column 1 = Colouring agents allowed in all cosmetic products;
Sub-column 2 = Colouring agents allowed in all cosmetic products except those intended to be applied in the vicinity of the eyes, in particular eye make-up and eye make-up remover;
Sub-column 3 = Colouring agents allowed exclusively in cosmetic products except cosmetic products intended to come into contact with the mucous membranes;
Sub-column 4 = Colouring agents allowed exclusively in cosmetic products intended to come into contact only briefly with the skin.
(1) | (2) | (3) | (4) | |||
---|---|---|---|---|---|---|
Name or colour index number | Colour | Type of product Field of application | Other requirements | |||
1 | 2 | 3 | 4 | |||
10006 | Green | X | ||||
10020 | Green | X | ||||
10316* | Yellow | X | ||||
11680 | Yellow | X | ||||
11710 | Yellow | X | ||||
11725 | Orange | X | ||||
11920 | Orange | X | ||||
12010 | Red | X | ||||
12085* | Red | X | 3 per cent maximum concentration in the finished product | |||
12120 | Red | X | ||||
12150 | Red | X | ||||
12370 | Red | X | ||||
12420 | Red | X | ||||
12480 | Brown | X | ||||
12490 | Red | X | ||||
12700 | Yellow | X | ||||
13015 | Yellow | X | E 105 | |||
14270 | Orange | X | E 103 | |||
14700 | Red | X | ||||
14720 | Red | X | E 122 | |||
14815 | Red | X | E 125 | |||
15510* | Orange | X | ||||
15525 | Red | X | ||||
15580 | Red | X | ||||
15620 | Red | X | ||||
15630* | Red | X | 3 per cent maximum concentration in the finished product | |||
15800 | Red | X | ||||
15850* | Red | X | ||||
15865* | Red | X | ||||
15880 | Red | X | ||||
15980 | Orange | X | E 111 | |||
15985* | Yellow | X | E 110 | |||
16035 | Red | X | ||||
16185 | Red | X | E 123 | |||
16230 | Orange | X | ||||
16255* | Red | X | E 124 | |||
16290 | Red | X | E 126 | |||
17200* | Red | X | ||||
18050 | Red | X | ||||
18130 | Red | X | ||||
18690 | Yellow | X | ||||
18736 | Red | X | ||||
18820 | Yellow | X | ||||
18965 | Yellow | X | ||||
19140* | Yellow | X | E 102 | |||
20040 | Yellow | X | Maximum 3,3'-dimethyl-benzidine concentration in the colouring agent: 5 mg/kg | |||
20170 | Orange | X | ||||
20470 | Black | X | ||||
21100 | Yellow | X | Maximum 3,3'-dichloro-benzidine concentration in the colouring agent: 5 mg/kg | |||
21108 | Yellow | X | Maximum 3,3'-dichloro-benzidine concentration in the colouring agent: 5 mg/kg | |||
21230 | Yellow | X | ||||
24790 | Red | X | ||||
26100 | Red | X | Purity criteria: aniline ≤0.2 per cent, 2-naphthol ≤0.2 per cent, azobenzen-4-amine ≤0.1 per cent, 1-phenylazo-2-naphthol ≤3 per cent, 1-[2-(phenylazo)phenylazo]-2-naphthol ≤2 per cent | |||
27290* | Red | X | ||||
27755 | Black | X | E 152 | |||
28440 | Black | X | E 151 | |||
40215 | Orange | X | ||||
40800 | Orange | X | ||||
40820 | Orange | X | E 160e | |||
40825 | Orange | X | E 160f | |||
40850 | Orange | X | E 161g | |||
42045 | Blue | X | ||||
42051* | Blue | X | E 131 | |||
42053 | Green | X | ||||
42080 | Blue | X | ||||
42090 | Blue | X | ||||
42100 | Green | X | ||||
42170 | Green | X | ||||
42510 | Violet | X | ||||
42520 | Violet | X | Maximum concentration in the finished product: 5 mg/kg | |||
42735 | Blue | X | ||||
44045 | Blue | X | ||||
44090 | Green | X | E 142 | |||
45100 | Red | X | ||||
45190 | Violet | X | ||||
45220 | Red | X | ||||
45350 | Yellow | X | 6 per cent maximum concentration in the finished product | |||
45370* | Orange | X | Not more than 1 per cent 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 2 per cent 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | |||
45380* | Red | X | as immediately above | |||
45396 | Orange | X | When used in lipstick, the colouring agent is allowed only in free acid form and in a maximum concentration of 1 per cent | |||
45405 | Red | X | Not more than 1 per cent 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 2 per cent 2-(bromo-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid | |||
45410* | Red | X | as immediately above | |||
45425 | Red | X | Not more than 1 per cent 2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid and 3 per cent 2-(iodo-6-hydroxyl-3-oxo-3H-xanthen-9-yl)benzoic acid | |||
45430* | Red | X | as immediately above, E 127 | |||
47000 | Yellow | X | ||||
47005 | Yellow | X | E 104 | |||
50325 | Violet | X | ||||
50420 | Black | X | ||||
51319 | Violet | X | ||||
58000 | Red | X | ||||
59040 | Green | X | ||||
60724 | Violet | X | ||||
60725 | Violet | X | ||||
60730 | Violet | X | ||||
61565 | Green | X | ||||
61570 | Green | X | ||||
61585 | Blue | X | ||||
62045 | Blue | X | ||||
69800 | Blue | X | E 130 | |||
69825 | Blue | X | ||||
71105 | Orange | X | ||||
73000 | Blue | X | ||||
73015 | Blue | X | E 132 | |||
73360 | Red | X | ||||
73385 | Violet | X | ||||
73900 | Violet | X | ||||
73915 | Red | X | ||||
74100 | Blue | X | ||||
74160 | Blue | X | ||||
74180 | Blue | X | ||||
74260 | Green | X | ||||
75100 | Yellow | X | ||||
75120 | Orange | X | E 160b | |||
75125 | Yellow | X | E 160d | |||
75130 | Orange | X | E 160a | |||
75135 | Yellow | X | E 161d | |||
75170 | White | X | ||||
75300 | Yellow | X | E 100 | |||
75470 | Red | X | E 120 | |||
75810 | Green | X | E 140 and E 141 | |||
77000 | White | X | E 173 | |||
77002 | White | X | ||||
77004 | White | X | ||||
77007 | Blue | X | ||||
77015 | Red | X | ||||
77120 | White | X | ||||
77163 | White | X | ||||
77220 | White | X | E 170 | |||
77231 | White | X | ||||
77266 | Black | X | ||||
77267 | Black | X | ||||
77268:1 | Black | X | E 153 | |||
77288 | Green | X | Free from chromate ions | |||
77289 | Green | X | Free from chromate ions | |||
77346 | Green | X | ||||
77400 | Brown | X | ||||
77480 | Brown | X | E 175 | |||
77489 | Orange | X | E 172 | |||
77491 | Red | X | E 172 | |||
77492 | Yellow | X | E 172 | |||
77499 | Black | X | E 172 | |||
77510 | Blue | X | Free from cyanide ions | |||
77713 | White | X | ||||
77742 | Violet | X | ||||
77745 | Red | X | ||||
77820 | White | X | E 174 | |||
77891 | White | X | E 171 | |||
77947 | White | X | ||||
Acid red 195 | Red | X | ||||
Aluminium, zinc, magnesium and calcium stearates | White | X | ||||
Anthocyanins | Red | X | E 163 | |||
Beetroot red | Red | X | E 162 | |||
Bromocresol green | Green | X | ||||
Bromothymol blue | Blue | X | ||||
Caramel | Brown | X | E 150 | |||
Capsanthin, capsorubin | Orange | X | E 160c | |||
Lactoflavin | Yellow | X | E 101 |
In column 3 of this Schedule, the entry “X” in a sub-column means that the colouring agent must not be used other than as follows—
Sub-column 1 = Colouring agents allowed in all cosmetic products;
Sub-column 2 = Colouring agents allowed in all cosmetic products except those intended to be applied in the vicinity of the eyes, in particular eye make-up and eye make-up remover;
Sub-column 3 = Colouring agents allowed exclusively in cosmetic products intended not to come into contact with the mucous membranes;
Sub-column 4 = Colouring agents allowed exclusively in cosmetic products intended to come into contact only briefly with the skin.
(1) | (2) | (3) | (4) | (5) | |||
---|---|---|---|---|---|---|---|
Name or colour index number | Colour | Type of product Field of application | Other requirements | Cosmetic product supplied until | |||
1 | 2 | 3 | 4 | ||||
NOTE: There are presently no entries in this part.
Regulations 4(2) and 6(2)
In this Schedule, the matters specified in columns 3, 4, 5 and 6 which apply to a particular substance are those set out to the right of its name as mentioned in column 2; and the matters specified in columns 4, 5 and 6 which apply in any particular case are those set out to the right of the matter specified in column 3 which applies in that case. The substance may not be used or contained other than in the types of product specified in column 3. The concentration of the substance, when it is used as a preservative, in a product may not exceed the limit set out in column 4. Where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 5.
In column 4 of this Schedule, “A” indicates that the concentration of the substance in a product may exceed the limit set out in that column provided that—
(a)the presence of any excess of the substance in a product over the concentration so set out is not for the primary purpose of inhibiting the development of micro-organisms; and
(b)the purpose for which any such excess is present in the product is apparent from the labelling of the product.
In this Schedule—
“salts” means salts of the cations sodium, potassium, calcium, magnesium, ammonium and ethanolamines and of the anions chloride, bromide, sulphate and acetate;
“esters” means esters of methyl, ethyl, propyl, isopropyl, butyl, isobutyl and phenyl.
In column 4 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
All preservative substances containing formaldehyde or any substances named in this Schedule which release formaldehyde must be labelled with the warning “contains formaldehyde” when the concentration of formaldehyde in the final product exceeds 0.05 per cent.
Names which appear in square brackets in column 2 of this Schedule are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC(11).
(1) | (2) | (3) | (4) | (5) | (6) | |
---|---|---|---|---|---|---|
Reference Number | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information | |
1 | Benzoic acid, its salts and esters | All products | 0.5 per cent (acid) | A | — | — |
2 | Propionic acid and its salts | All products | 2 per cent (acid) | A | — | — |
3 | Salicylic acid and its salts | All products | 0.5 per cent (acid) | A | Not to be used in preparations for children under three years of age except for shampoos | Not to be used for children under three years of age (Solely for products which might be used for children under three years of age and which remain in prolonged contact with the skin) |
4 | Sorbic acid (hexa-2,4-dienoic acid) and its salts | All products | 0.6 per cent (acid) | A | — | — |
5 | Formaldehyde and paraformaldehyde | For oral hygiene | 0.1 per cent (expressed as free formaldehyde) | Not to be used in aerosol dispensers (sprays) | — | |
Except for oral hygiene (see also Part I of Schedule 2) | 0.2 per cent (expressed as free formaldehyde) | |||||
6 | ENTRY DELETED | |||||
7 | Biphenyl-2-ol [o-phenylphenol] and its salts | All products | 0.2 per cent (expressed as the phenol) | A | — | — |
8 | Pyrithione zinc (INN) [Zinc pyrithione] | Products rinsed off after use | 0.5 per cent | A | Not to be used in oral hygiene products | — |
9 | Inorganic sulphites and hydrogen sulphites | All products | 0.2 per cent (expressed as free SO2) | A | — | — |
10 | Sodium iodate | Products rinsed off after use | 0.1 per cent | — | — | |
11 | Chlorobutanol (INN) | All products | 0.5 per cent | Not to be used in aerosol dispensers (sprays) | Contains chlorobutanol | |
12 | 4-Hydroxybenzoic acid and its salts and esters [the Parabens] | All products | 0.4 per cent (acid) for 1 ester, 0.8 per cent (acid) for mixtures of esters | A | — | — |
13 | 3-Acetyl-6-methylpyran-2,4(3H)-dione [Dehydroacetic acid] and its salts | All products | 0.6 per cent (acid) | Not to be used in aerosol dispensers (sprays) | — | |
14 | Formic acid and its sodium salt | All products | 0.5 per cent (expressed as acid) | A | — | — |
15 | 3,3'-Dibromo-4,4'-hexamethylene-dioxydibenzamidine [Dibromohexamidine] and its salts (including isethionate) | All products | 0.1 per cent | — | — | |
16 | Thiomersal (INN) [Thimerosal] | Eye make-up and eye make-up remover | 0.007 per cent calculated as mercury. When mixed with other authorised mercury compounds total mercury concentration must not exceed 0.007 per cent | — | Contains thiomersal | |
17 | Phenylmercuric salts (including borate) | Eye make-up and eye make-up remover | 0.007 per cent calculated as mercury. When mixed with other authorised mercury compounds total mercury concentration must not exceed 0.007 per cent | — | Contains phenylmercuric compounds | |
18 | Undec-10-enoic acid [Undecylenic acid] and its salts | All products | 0.2 per cent (acid) | A | — | — |
19 | Hexetidine (INN) | Products rinsed off after use | 0.1 per cent | A | — | — |
20 | 5-Bromo-5-nitro-1,3-dioxane | Products rinsed off after use | 0.1 per cent | Avoid formation of nitrosamines | — | |
21 | Bronopol (INN) [2-Bromo-2-nitropropane-1,3-diol] | All products | 0.1 per cent | A | Avoid formation of nitrosamines | — |
22 | 2,4-Dichlorobenzyl alcohol [Dichlorobenzyl alcohol] | All products | 0.15 per cent | A | — | — |
23 | Triclocarban (INN) | All products | 0.2 per cent | A | Purity criteria: 3,3'4,4'-tetrachloro-azobenzene<1 mg/kg 3,3',4,4'-tetrachloro-azoxybenzene<1 mg/kg | — |
24 | 4-Chloro-m-cresol [p-Chloro-m-cresol] | Not to be used in products intended to come into contact with mucous membranes | 0.2 per cent | A | — | — |
25 | Triclosan (INN) | All products | 0.3 per cent | A | — | — |
26 | 4-Chloro-3,5-xylenol [Chloroxylenol] | All products | 0.5 per cent | A | — | — |
27 | 3,3'-Bis(1-hydroxymethyl-2,5-dioxoimidazolidin-4-yl)-1,1'-methylenediurea [Imidazolidinyl urea] | All products | 0.6 per cent | A | — | — |
28 | Poly(1-hexamethylene-biguanide hydrochloride) [Polyaminopropyl biguanide] | All products | 0.3 per cent | A | — | — |
29 | 2-Phenoxyethanol [Phenoxyethanol] | All products | 1.0 per cent | A | — | — |
30 | Hexamethylenetetramine (Methenamine (INN)) [Methenamine] | All products | 0.15 per cent | A | — | — |
31 | Methenamine 3-chloroallylochloride (INNM) [Quaternium-15] | All products | 0.2 per cent | — | — | |
32 | 1-(4-Chlorophenoxy)-1-(imidazol-1-yl)-3,3-dimethylbutan-2-one (Climbazole (INN)) [Climbazole] | All products | 0.5 per cent | A | — | — |
33 | 1,3-Bis(hydroxymethyl)-5,5-dimethylimidazolidine-2,4-dione [DMDM Hydantoin] | All products | 0.6 per cent | A | — | — |
34 | Benzyl alcohol (See also Part I of Schedule 2) | All products | 1.0 per cent | A | — | — |
35 | 1-Hydroxy-4-methyl-6-(2,4,4-trimethylpentyl)-2-pyridone and its monoethanolamine salt [Piroctone olamine] | Products rinsed off after use Other products | 1.0 per cent 0.5 per cent | A A | — — | — — |
36 | 1,2-Dibromo-2,4-dicyanobutane [Methyldibromo glutaronitrile] | All products | 0.1 per cent | Not to be used in cosmetic sunscreen products at a concentration exceeding 0.025 per cent | — | |
37 | 6,6-Dibromo-4,4-dichloro-2,2'-methylenediphenol [Bromochlorophen] | All products | 0.1 per cent | A | — | — |
38 | 4-Isopropyl-m-cresol [o-Cymen-5-ol] | All products | 0.1 per cent | — | — | |
39 | Mixture of 5-chloro-2-methylisothiazol-3(2H)-one and 2-methylisothiazol-3(2H)-one with magnesium chloride and magnesium nitrate [Methylchloroisothiazolinone and Methylisothiazolinone] | All products | 0.0015 per cent of a mixture in the ratio 3:1 of 5-chloro-2-methylisothiazol-3(2H)-one to 2-methylisothiazol-3(2H)-one | — | — | |
40 | 2-Benzyl-4-chlorophenol [Chlorophene] | All products | 0.2 per cent | — | — | |
41 | 2-Chloroacetamide [Chloroacetamide] | All products | 0.3 per cent | — | Contains chloroacetamide | |
42 | Chlorhexidine (INN) and its digluconate, diacetate and dihydrochloride | All products | 0.3 per cent | A | — | — |
43 | 1-Phenoxypropan-2-ol [Phenoxyisopropanol] (see also Part I of Schedule 2) | Products rinsed off after use | 1.0 per cent | — | — | |
44 | Alkyl (C12-C22)-trimethylammonium bromide and chloride (Cetrimonium bromide (INN) and Cetrimonium chloride (INNM)) | All products | 0.1 per cent | A | — | — |
45 | 4,4-Dimethyl-1,3-oxazolidine [Dimethyl oxazolidine] | All products | 0.1 per cent | The pH of the finished product must not be lower than 6 | — | |
46 | 1-[1,3-Bis(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1,3-bis(hydroxymethyl)urea [Diazolidinyl urea] | All products | 0.5 per cent | — | — | |
47 | Hexamidine (INN) (4,4'-(Hexamethylene-dioxy)dibenzamidine) and its salts, including isethionate and p-hydroxybenzoate | All products | 0.1 per cent | A | — | — |
48 | Glutaraldehyde (pentane-1,5-dial) [Glutaral] | All products | 0.1 per cent | Prohibited in aerosols (sprays) | Contains glutaraldehyde (where glutaraldehyde concentration in the finished product exceeds 0.05 per cent) | |
49 | 5-Ethyl-3,7-dioxa-1-azabicyclo[3.3.0]octane[7-Ethylbicyclooxazolidine] | All products | 0.3 per cent | Prohibited in oral hygiene products and in products intended to come into contact with mucous membranes | — | |
50 | Chlorphenesin (INN) [Chlorphenesin] | All products | 0.3 per cent | — | — | |
51 | Sodium N-hydroxymethylglycinate [Sodium hydroxymethyl-glycinate] | All products | 0.5 per cent | — | — | |
52 | Silver chloride deposited on titanium dioxide | Not to be used in products for children under three years of age, in oral hygiene products and in products intended for application around the eyes and on the lips | 0.004 per cent calculated as silver chloride | The ratio of titanium dioxide to silver chloride shall be 4:1 by mass | — |
(1) | (2) | (3) | (4) | (5) | (6) | (7) |
---|---|---|---|---|---|---|
Reference Number in Annex VI Part 2 of the Directive | Name of substance | Purpose of substance or type of product | Maximum concentration of substance in product | Other requirements | Required information | Preservative supplied until |
Note: Entry number 15 is deleted with effect from the dates specified in regulation 1(4) and entry numbers 2 and 30 are deleted with effect from the dates specified in regulation 1(6). Until then entry number 15 in Part II of Schedule 4 to S.I. 1989/2233 (as amended by S.I. 1995/1478 but not by S.I. 1996/1446) and entry numbers 2 and 30 in Part II of Schedule 4 to S.I. 1989/2233 (amended most recently by S.I. 1996/1446) continue in force. | ||||||
1 to 15 | ENTRIES DELETED (see Note) | |||||
16 | Benzalkonium chloride (INN), bromide and saccharinate (Alkyl(C8-C18) benzyldimethyl-ammonium chloride, bromide and saccharinate) | All products | 0.1 per cent A | — | — | 30.06.1997 |
17 to 20 | ENTRIES DELETED | |||||
21 | Benzylhemiformal (a 1:1 mixture of benzyloxymethanol and benzyloxy-methoxymethanol) | Products rinsed off after use | 0.03 per cent | — | — | 30.06.1997 |
22 to 28 | ENTRIES DELETED | |||||
29 | 3-lodoprop-2-ynyl butylcarbamate | All products | 0.1 per cent | — | — | 30.06.1997 |
30 | ENTRY DELETED (see Note) |
Regulations 4(2) and 6(2)
In this Schedule, the matters specified in columns 3, 4 and 5 which apply to a particular substance are those set out to the right of its name as mentioned in column 2. The concentration of the substance in a product may not exceed the limit specified in column 3. Where a product is intended to be mixed with another product in specified proportions before use, the level of concentration shall be calculated by reference to the mixture. Other requirements are specified in column 4. In column 3 of this Schedule, the percentage concentration is measured by reference to mass (m/m) unless a contrary intention appears.
Names which appear in square brackets in column 2 are the International Nomenclature Cosmetic Ingredient names of the substances in question given in the inventory of ingredients employed in cosmetic products drawn up in accordance with the provisions of the Directive and contained in Commission Decision 96/335/EC(14)
(1) | (2) | (3) | (4) | (5) |
---|---|---|---|---|
Reference Number | Name of substance | Maximum concentration of substance in product | Other requirements | Required information |
1 | 4-Aminobenzoic acid [PABA] | 5 per cent | — | — |
2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulphate [Camphor benzalkonium methosulfate] | 6 per cent | — | — |
3 | Homosalate (INN) | 10 per cent | — | — |
4 | Oxybenzone (INN) [Benzophenone-3] | 10 per cent | — | Contains oxybenzone. (Not required when concentration is not more than 0.5 per cent, and when the substance is only intended to protect the product.) |
5 | ENTRY DELETED | |||
6 | 2-Phenylbenzimidazole-5-sulphonic acid [Phenylbenzimidazole sulfonic acid] and its potassium, sodium and triethanolamine salts | 8 per cent (expressed as acid) | — | — |
7 | 3,3'-(1,4-Phenylenedimethylene)bis(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonic acid) [Terephthalylidene dicamphor sulfonic acid] and its salts | 10 per cent (expressed as acid) | — | — |
8 | 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl) propane-1,3-dione (Avobenzone (INN)) [Butyl methoxy dibenzoylmethane] | 5 per cent | — | — |
9 | α-(2-Oxoborn-3-ylidene)toluene-4-sulphonic acid [Benzylidene camphor sulfonic acid] and its salts | 6 per cent (expressed as acid) | — | — |
10 | 2-Ethylhexyl-2-cyano-3,3-diphenylacrylate [Octocrylene] | 10 per cent (expressed as acid) | — | — |
11 | Polymer of N-{(2 and 4)-[2-oxoborn-3-ylidene)methyl]benzyl}acrylamide [Polyacrylamidomethyl benzylidene camphor] | 6 per cent | — | — |
(1) | (2) | (3) | (4) | (5) | (6) |
---|---|---|---|---|---|
Reference Number | Name of substance | Maximum concentration of substance in product | Other requirements | Required information | UV filter supplied until |
Note: Entry numbers 33 and 34 are deleted with effect from the dates specified in regulation 1(6). Until then the corresponding entries in Part II of Schedule 5 to S.I. 1989/2233 (amended most recently by S.I. 1996/1446) continue in force. | |||||
1 | ENTRY DELETED | ||||
2 | Ethoxylated ethyl 4-aminobenzoate [PEG-25 PABA] | 10 per cent | — | — | 30.6.1997 |
3–4 | ENTRIES DELETED | ||||
5 | 2-Ethylhexyl 4-dimethylamino-benzoate [Octyl dimethyl PABA] | 8 per cent | — | — | 30.6.1997 |
6 | 2-Ethylhexyl salicylate [Octyl salicylate] | 5 per cent | — | — | 30.6.1997 |
7–11 | ENTRIES DELETED | ||||
12 | Isopentyl 4-methoxycinnamate, mixed isomers [Isoamyl p-methoxycinnamate] | 10 per cent | — | — | 30.6.1997 |
13 | 2-Ethylhexyl 4-methoxycinnamate [Octyl methoxycinnamate] | 10 per cent | — | — | 30.6.1997 |
14–16 | ENTRIES DELETED | ||||
17 | 2-Hydroxy-4-methoxybenzo-phenone-5-sulphonic acid [Benzophenone-4] and its sodium salt [Benzophenone-5] (Sulisobenzone (INN) and Sulisobenzone sodium (INNM)) | 5 per cent (expressed as acid) | — | — | 30.6.1997 |
18–24 | ENTRIES DELETED | ||||
25 | 3-(4-Methylbenzyl-idene)bornan-2-one [4-Methylbenzylidene camphor] | 6 per cent | — | — | 30.6.1997 |
26 | 3-Benzylidenebornan-2-one [3-Benzylidene camphor] | 6 per cent | — | — | 30.6.1997 |
27–28 | ENTRIES DELETED | ||||
29 | 4-Isopropylbenzyl salicylate [Isopropylbenzyl salicylate] | 4 per cent | — | — | 30.6.1997 |
30–31 | ENTRIES DELETED | ||||
32 | Tris(2-ethylhexyl) 4,4',4"-(1,3,5-triazin-2,4,6-triyltriimino)- tribenzoate [Octyl triazone] | 5 per cent | — | — | 30.6.1997 |
33–34 | ENTRIES DELETED (see Note) |
Regulations 6(6) and (11)
Regulation 11
1. The name or trade name and address or registered office of the applicant.
2. Precise identification of the cosmetic ingredient for which confidentiality is requested, namely—
(a)where they exist, the CAS, EINECS and colour index numbers, the chemical name, the IUPAC name, the INCI name, the European Pharmacopoeia name, the International Non-proprietary Name as recommended by the World Health Organization and the common name as provided for in the common ingredients nomenclature;
(b)the Elincs name and the official number allocated to it if it has been notified pursuant to Council Directive 67/548/EEC and an indication of the decision to approve or refuse any request for confidentiality made under Article 19 of that Directive;
(c)where the names or numbers referred to in sub-paragraphs (a) and (b) above do not exist, for example in the case of certain ingredients of natural origin, the name of the base material, the name of the part of the plant or animal used and the names of the cosmetic ingredient’s compounds, such as solvents.
3. The evaluation of the safety for human health of the cosmetic ingredient as used in the finished cosmetic product or products taking into account the cosmetic ingredient’s toxicological profile, chemical structure and the level of exposure as specified in regulation 8(1)(d) and carried out in accordance with the requirements of regulations 8(2) and (3).
4. The envisaged use of the cosmetic ingredient and in particular the different categories of cosmetic products in which it will be used.
5. A detailed justification of why confidentiality is sought addressing for example—
(a)the fact that the identity of the cosmetic ingredient or its function in the cosmetic product to be supplied has not been described in the literature accompanying the cosmetic product and is unknown to other manufacturers or suppliers of cosmetic products;
(b)the fact that the information is not yet in the public domain even though a patent application has been lodged for the cosmetic ingredient or its use;
(c)the fact that if the information were known it would be easily reproducible, to the detriment of the applicant.
6.—(a) If known, the name of each cosmetic product which is to contain the cosmetic ingredient and if different names are to be used in other member States, precise details of each one of them.
(b)If the name of a cosmetic product is not yet known, it may be communicated at a later date, but at least 15 days before the cosmetic product is supplied.
(c)If the cosmetic ingredient is used in several products, one request shall suffice, provided that the cosmetic products are clearly indicated to the competent authority.
7. A statement setting out whether a request has been submitted to the competent authority of any other member State in respect of the cosmetic ingredient for which confidentiality is sought and particulars on the outcome of any such request.
1. The registration number referred to in regulation 11(5) shall consist of seven digits, the first two corresponding to the year of approval of confidentiality, the second two to the code assigned to each member State, as referred to in paragraph 2 below, and the final three digits assigned by the competent authority.
2. The code allocated to the United Kingdom is 06.
Regulation 14
1. In this Schedule—
“Annex A” means the Annex to Commission Directive No. 80/1335/EEC(17) as amended by Commission Directive No. 87/143/EEC(18);
“Annex B” means the Annex to Commission Directive No. 82/434/EEC(19) as amended by Commission Directive No. 90/207/EEC(20);
“Annex C” means the Annex to Commission Directive No. 83/514/EEC(21);
“Annex D” means the Annex to Commission Directive No. 85/490/EEC(22);
“Annex E” means the Annex to Commission Directive No. 93/73/EEC(23);
“Annex F” means the Annex to Commission Directive No. 95/32/EC(24);
“Annex G” means the Annex to Commission Directive No. 96/45/EC(25);
“purchase” means purchase for the purpose of carrying out a test.
2. An enforcement authority intending to purchase a cosmetic product shall purchase a sufficient laboratory sample, as defined in paragraph 2.3 of Part I of Annex A, for the purpose of Annex A; and, for the purposes of the definition of “total sample” in paragraph 2.2 of Part I of Annex A, samples shall be regarded as having the same batch number if—
(a)the means of identifying the batch referred to in regulation 6(2)(g) above shows that they were manufactured in the same batch; or
(b)in the case of a product not manufactured in a batch, the reference referred to in regulation 6(2)(g) above shows that they are derived from the same unit of production; or
(c)in the case of a product which does not comply with the requirements of regulation 6(2)(g) above, the officer effecting the purchase has reasonable cause to believe that they were manufactured in the same batch or are derived from the same unit of production, as the case may be.
3. The immediate container, if any, of a cosmetic product purchased by an enforcement authority shall not have been opened by, on behalf of or at the request of the enforcement authority before the purchase takes place and the container shall not thereafter be opened except in accordance with paragraph 5.3 of Part I of Annex A and paragraph 1.2 of Part II of Annex A.
4. As soon as an enforcement authority has purchased a cosmetic product, the officer effecting the purchase shall—
(a)either—
(i)place a seal on the product’s container or outer packaging, or
(ii)place the product in a container and forthwith place a seal on that container, in such a way that the product’s immediate container cannot be opened or (in the case of a product which was not in a container when it was purchased) the product cannot be touched without (in either case) the seal being broken in such a manner that it would be apparent thereafter that it had been broken, and
(b)attach to the product a label indicating—
(i)the name of the product,
(ii)the date, time and place at which the product was purchased,
(iii)his own name, and
(iv)the name of the enforcement authority making the purchase.
5.—(1) Subject to sub-paragraph (2) below, the provisions of Part I of Annex A, other than paragraphs 3.1, 3.2 and 4, and of Part II of Annex A, other than paragraph 1.4, shall be complied with in the sampling of cosmetic products and the laboratory preparation of test portions.
(2) Where, because of the way in which a cosmetic product is put up for sale, it is not practicable for Part II of Annex A to be complied with, it shall be prepared for testing in accordance with good analytical practice, and the person so preparing it shall record in writing the method of preparation which he has used.
6.—(1) Any test to determine whether a cosmetic product contains a significant amount of free sodium hydroxide or free potassium hydroxide shall be carried out in accordance with paragraphs 1 to 4 of Part III of Annex A.
(2) Any test to determine the amount of free sodium hydroxide or free potassium hydroxide in a hair straightener product or a nail cuticle solvent product shall be carried out in accordance with paragraphs 1, 2, 3 and 5 of Part III of Annex A.
(3) Any test to determine whether a hair-care product contains oxalic acid or any alkaline salt of oxalic acid or to determine the amount of such a substance in a hair-care product shall, subject to the limitation specified in the second sentence of paragraph 1 of Part IV of Annex A, be carried out in accordance with the said Part IV.
(4) Any test to determine the amount of chloroform in toothpaste shall, subject to the limitation specified in the second sentence of paragraph 1 of Part V of Annex A, be carried out in accordance with the said Part V.
(5) Any test to determine the amount of zinc chloride, zinc sulphate or zinc 4-hydroxybenzenesulphonate by virtue of their zinc contents in a cosmetic product shall be carried out in accordance with Part VI of Annex A and Commission Directive 87/143/EEC(26), and shall take into account paragraph 11 of Part VII of Annex A.
(6) Any test to determine whether a cosmetic product contained in an aerosol dispenser or a cream, emulsion, lotion, gel or oil intended to be applied to the skin contains 4-hydroxybenzenesulphonic acid, or to determine the amount of that acid in such a product, shall be carried out in accordance with Part VII of Annex A.
(7) Any test to determine whether a hair-care product contains persulphate, bromate or hydrogen peroxide shall be carried out in accordance with Part A of Part I of Annex B.
(8) Any test to determine whether a hair-care product contains barium peroxide shall be carried out in accordance with Part B of Part I of Annex B.
(9) Any test to determine the amount of hydrogen peroxide in a hair-care product shall be carried out in accordance with Part C of Part I of Annex B.
(10) Any test to determine whether a hair-dye contains any of the oxidation colourants specified in paragraph 1 of Part II of Annex B, or to determine the amount of such a substance in a hair-dye, shall be carried out in accordance with the said Part II.
(11) Any test to determine whether a cosmetic product contains nitrite, or to determine the amount of that substance in a cosmetic product, shall be carried out in accordance with Part III of Annex B.
(12) Any test to determine whether a cosmetic product contains free formaldehyde, or to determine the amount of that substance in a cosmetic product, shall be carried out in accordance with Part IV of Annex B.
(13) Any test to determine the amount of resorcinol in a shampoo or hair lotion shall, subject to the limitation specified in the second sentence of paragraph 1 of Part V of Annex B, be carried out in accordance with the said Part V.
(14) Any test to determine the amount of methanol in relation to ethanol or propan-2-ol in a cosmetic product shall be carried out in accordance with Part VI of Annex B.
(15) Any test to determine the amount of dichloromethane or 1,1,1-trichloroethane in a cosmetic product shall be carried out in accordance with paragraphs 1 to 10 of that part of Annex C which is headed “Determination of dichloromethane and 1,1,1-trichloroethane”.
(16) Any test to determine whether a cosmetic product contains quinolin-8-ol or bis(8-hydroxyquinolinium) sulphate, or to determine the amount of such a substance in a cosmetic product, shall be carried out in accordance with paragraphs 1 to 9 of that part of Annex C which is headed “Identification and determination of quinolin-8-ol and bis(8-hydroxyquinolinium) sulphate”.
(17) Any test to determine the amount of ammonia in a cosmetic product shall be carried out in accordance with paragraphs 1 to 8 of that part of Annex C which is headed “Determination of ammonia”.
(18) Any test to determine whether a cosmetic product contains nitromethane, or to determine the amount of that substance in a cosmetic product, shall be carried out in accordance with paragraphs 1 to 7 of that part of Annex C which is headed “Identification and determination of nitromethane”.
(19) Any test to determine whether a hair waving, hair straightening or depilatory product contains mercaptoacetic acid (thioglycolic acid), or to determine the amount of that substance in such a product, shall be carried out in accordance with paragraphs 1 to 6 of that part of Annex C which is headed “Identification and determination of mercaptoacetic acid in hair-waving, hair-straightening and depilatory products”.
(20) Any test to determine whether a cosmetic product contains hexachlorophene (INN) shall be carried out in accordance with paragraphs 1 to 7 of Part A of that part of Annex C which is headed “Identification and determination of hexachlorophene”.
(21) Any test to determine the amount of hexachlorophene (INN) in a cosmetic product shall be carried out in accordance with paragraphs 1 to 9 of Part B of that part of Annex C which is headed “Identification and determination of hexachlorophene”.
(22) Any test to determine the amount of tosylchloramide sodium (INN) in a cosmetic product shall be carried out in accordance with paragraphs 1 to 9 of that part of Annex C which is headed “Quantitative determination of tosylchloramide sodium (INN) (chloramine-T)”.
(23) Any test to determine the total amount of fluorine in dental creams shall be carried out in accordance with paragraphs 1 to 8 of that part of Annex C which is headed “Determination of total fluorine in dental creams”.
(24) Any test to determine whether a cosmetic product contains organomercury compounds shall be carried out in accordance with paragraphs 1 to 4 of Part A of that part of Annex C which is headed “Identification and determination of organomercury compounds”.
(25) Any test to determine the amount of organomercury compounds in a cosmetic product shall be carried out in accordance with paragraphs 1 to 7 of Part B of that part of Annex C which is headed “Identification and determination of organomercury compounds”.
(26) Any test to determine the amount of alkali sulphides or alkaline earth sulphides in a cosmetic product shall be carried out in accordance with paragraphs 1 to 8 of that part of Annex C which is headed “Determination of alkali and alkaline earth sulphides”.
(27) Any test for the identification and determination of the amount of glycerol 1-(4-aminobenzoate) in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of glycerol 1-(4-aminobenzoate)”.
(28) Any test to determine the amount of chlorobutanol (INN) in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Determination of chlorobutanol”.
(29) Any test for the identification and determination of the amount of quinine in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of quinine”.
(30) Any test for the identification and determination of inorganic sulphites and hydrogen sulphites in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of inorganic sulphites and hydrogen sulphites”.
(31) Any test for the identification and determination of chlorates of the alkali metals in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of chlorates of the alkali metals”.
(32) Any test for the identification and determination of sodium iodate in a cosmetic product shall be carried out in accordance with that part of Annex D which is headed “Identification and determination of sodium iodate”.
(33) Any test for the identification and determination of silver nitrate in a cosmetic product shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of silver nitrate in cosmetic products”.
(34) Any test for the identification and determination of selenium disulphide in anti-dandruff shampoos shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of selenium disulphide in anti-dandruff shampoos”.
(35) Any test for the determination of soluble barium and soluble strontium in pigments in the form of salts or lakes shall be carried out in accordance with that part of Annex E which is headed “Determination of soluble barium and strontium in pigments in the form of salts or lakes”.
(36) Any test for the identification and determination of benzyl alcohol in a cosmetic product shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of benzyl alcohol in cosmetic products”.
(37) Any test for the identification of zirconium and the determination of zirconium, aluminium and chlorine in non-aerosol anti-perspirants shall be carried out in accordance with that part of Annex E which is headed “Identification of zirconium, and determination of zirconium, aluminium and chlorine in non-aerosol anti-perspirants”.
(38) Any test for the identification and determination of hexamidine, dibromohexamidine, dibromopropamidine and chlorhexidine in a cosmetic product shall be carried out in accordance with that part of Annex E which is headed “Identification and determination of hexamidine, dibromohexamidine, dibromopropamidine and chlorhexidine”.
(39) Any test for the identification and determination of benzoic acid, 4-hydroxybenzoic acid, sorbic acid, salicylic acid and propionic acid in a cosmetic product shall be carried out in accordance with that part of Annex F which is headed “Identification and determination of benzoic acid, 4-hydroxybenzoic acid, sorbic acid, salicylic acid and propionic acid in cosmetic products”.
(40) Any test for the identification and determination of hydroquinone, hydroquinone monomethylether, hydroquinone monoethylether and hydroquinone monobenzylether (monobenzone) in a cosmetic product shall be carried out in accordance with that part of Annex F which is headed “Identification and determination of hydroquinone, hydroquinone monomethylether, hydroquinone monoethylether and hydroquinone monobenzylether in cosmetic products”.
(41) Any test for the identification and determination of 2-phenoxyethanol, 1-phenoxypropan-2-ol, and methyl, ethyl, propyl, butyl and benzyl 4-hydroxybenzoate in a cosmetic product shall be carried out in accordance with Annex G.
Regulation 1(9)
(1) | (2) |
---|---|
Regulations revoked | References |
The Cosmetic Products (Safety) Regulations 1989 | S.I. 1989/2233 |
The Cosmetic Products (Safety) (Amendment) Regulations 1990 | S.I. 1990/1812 |
The Cosmetic Products (Safety) (Amendment) Regulations 1991 | S.I. 1991/447 |
The Cosmetic Products (Safety) (Amendment) Regulations 1992 | S.I. 1992/1525 |
The Cosmetic Products (Safety) (Amendment) Regulations 1993 | S.I. 1993/1539 |
The Cosmetic Products (Safety) (Amendment) Regulations 1994 | S.I. 1994/1529 |
The Cosmetic Products (Safety) (Amendment) Regulations 1995 | S.I. 1995/1478 |
The Cosmetic Products (Safety) (Amendment) Regulations 1996 | S.I. 1996/1446 |
O.J. No. L187, 12.7.76, p.1.
O.J. No. L147, 9.6.75, p.13.
O.J. No. L132, 1.6.1996, p.1.
See Directives 86/199/EEC, 87/137/EEC, 88/233/EEC, 88/667/EEC, 89/174/EEC, 90/121/EEC, 91/184/EEC, 92/8/EEC, 92/86/EEC, 93/47/EEC, 94/32/EC, 95/34/EC.
O.J. No. 115, 11.11.62, p.2645.
Council Directives Nos. 65/469/EEC, 67/653/EEC, 68/419/EEC, 70/358/EEC, 76/399/EEC, 78/144/EEC, 81/20/EEC and 85/7/EEC (O.J. Nos. L178, 26.10.65, p.2793; L263, 30.10.67, p.4; L309, 24.12.68, p.24; L157, 18.7.70, p.36; L108, 26.4.76, p.19; L44, 15.2.78, p.20; L43, 14.2.81, p.11; L2, 3.1.85, p.22).
Annexes I and VII to the Act of Accession of 22 January 1972, as adjusted by the Council Decision of 1 January 1973 (O.J. No. L2, 1.1.73, p.1).
Council Directive 94/36/EC (O.J. No. L237, 10.9.1994, p.13) and Commission Directive 95/45/EC (O.J. No. L226, 22.9.1995, p.1).
See Directives 86/179/EEC, 87/137/EEC, 88/233/EEC, 88/667/EEC, 89/174/EEC, 90/121/EEC, 91/184/EEC, 92/8/EEC, 92/86/EEC.
See Directives 86/179/EEC, 87/137/EEC, 88/233/EEC, 89/174/EEC, 90/121/EEC, 91/184/EEC, 92/8/EEC, 92/86/EEC.
O.J. No. L132, 1.6.1996, p.1.
See Directives 86/199/EEC, 87/137/EEC, 88/233/EEC, 89/174/EEC, 90/121/EEC, 91/184/EEC, 92/8/EEC, 92/86/EEC, 93/47/EEC, 94/32/EC, 95/34/EC, 96/41/EC.
See Directives 86/199/EEC, 87/137/EEC, 88/233/EEC, 89/174/EEC, 91/184/EEC, 92/86/EEC, 94/32/EC, 96/41/EC.
O.J. No. L132, 1.6.1996, p.1.
See Directives 83/574/EEC, 91/184/EEC, 92/86/EEC, 93/47/EEC, 94/32/EC, 95/34/EC, 96/41/EC.
See Directives 83/574/EEC, 89/174/EEC, 90/121/EEC, 92/8/EEC, 92/86/EEC, 93/47/EEC, 94/32/EC, 95/34/EC, 96/41/EC.
O.J. No. L383, 31.12.80, p.27.
O.J. No. L57, 27.2.87, p.56.
O.J. No. L185, 30.6.82, p.1.
O.J. No. L108, 28.4.90, p.92.
O.J. No. L291, 24.10.83, p.9.
O.J. No. L295, 7.11.85, p.30
O.J. No. L231, 14.9.93, p.34.
O.J. No. L178, 28.7.95, p.20.
O.J. No. L213, 2.7.1996, p.8.
O.J. No. L57, 27.2.87, p.56.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: